FI63596C - MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER - Google Patents
MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER Download PDFInfo
- Publication number
- FI63596C FI63596C FI813251A FI813251A FI63596C FI 63596 C FI63596 C FI 63596C FI 813251 A FI813251 A FI 813251A FI 813251 A FI813251 A FI 813251A FI 63596 C FI63596 C FI 63596C
- Authority
- FI
- Finland
- Prior art keywords
- nucleic acid
- reagent
- fragment
- labeled
- plasmid
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 88
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 75
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 75
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 60
- 238000009396 hybridization Methods 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 45
- 239000012634 fragment Substances 0.000 claims abstract description 42
- 239000012445 acidic reagent Substances 0.000 claims abstract description 23
- 239000007787 solid Substances 0.000 claims abstract description 22
- 239000013612 plasmid Substances 0.000 claims description 40
- 230000000813 microbial effect Effects 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 20
- 241000701161 unidentified adenovirus Species 0.000 claims description 18
- 241000700605 Viruses Species 0.000 claims description 16
- 241000588724 Escherichia coli Species 0.000 claims description 14
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 241000710961 Semliki Forest virus Species 0.000 claims description 9
- 238000002405 diagnostic procedure Methods 0.000 claims description 6
- 108020004511 Recombinant DNA Proteins 0.000 claims description 5
- 108010065511 Amylases Proteins 0.000 claims 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 244000005700 microbiome Species 0.000 abstract 10
- 239000003550 marker Substances 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 238000009877 rendering Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 66
- 239000000523 sample Substances 0.000 description 59
- 210000004027 cell Anatomy 0.000 description 35
- 244000309466 calf Species 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 210000001541 thymus gland Anatomy 0.000 description 15
- 238000001514 detection method Methods 0.000 description 10
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000003612 virological effect Effects 0.000 description 7
- 239000004382 Amylase Substances 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 230000002285 radioactive effect Effects 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 241001646716 Escherichia coli K-12 Species 0.000 description 4
- 108020005202 Viral DNA Proteins 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 101150115693 ompA gene Proteins 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 208000009889 Herpes Simplex Diseases 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 241000700584 Simplexvirus Species 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 241001493065 dsRNA viruses Species 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- 241001131785 Escherichia coli HB101 Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000688 enterotoxigenic effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010072454 CTGCAG-specific type II deoxyribonucleases Proteins 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 101710197658 Capsid protein VP1 Proteins 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241001397104 Dima Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241001524679 Escherichia virus M13 Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000701109 Human adenovirus 2 Species 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 101710116435 Outer membrane protein Proteins 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 241000724206 Phage M13mp7 Species 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 101710106388 Structural protein VP1 Proteins 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 108010087302 Viral Structural Proteins Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010045649 agarase Proteins 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 101150042295 arfA gene Proteins 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 229940094991 herring sperm dna Drugs 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- BAPROVDXKNPHAM-UHFFFAOYSA-N n-(2-aminoethyl)-3-(3,5-ditert-butyl-4-hydroxyphenyl)propanamide Chemical compound CC(C)(C)C1=CC(CCC(=O)NCCN)=CC(C(C)(C)C)=C1O BAPROVDXKNPHAM-UHFFFAOYSA-N 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 101150087557 omcB gene Proteins 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 101150079601 recA gene Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
6359663596
Nukleiinihappojen kerroshybridisaatioon perustuva mikrobi-diagnostinen menetelmä ja menetelmässä käytettäviä reagenssien yhdistelmiä 5Microbial diagnostic method based on layer hybridization of nucleic acids and combinations of reagents used in the method 5
Keksinnön kohteena on nukleiinihappojen kerroshybridisaatioon kiinteällä kantajalla perustuva mikrobidiagnosti-10 nen menetelmä yhden tai useamman mikrobin ja/tai mikrobi- ryhmän yhtäaikaiseksi osoittamiseksi yhdestä jakamattomasta näytteestä sekä menetelmässä käytettävä sarja reagenssien yhdistelmiä.The invention relates to a microbial diagnostic method based on layered hybridization of nucleic acids on a solid support for the simultaneous detection of one or more microbes and / or microbial groups in a single undivided sample and to a series of reagent combinations used in the method.
15 Perinteisessä mikrobidiagnostiikassa mikrobin läsnäolo tutkittavissa näytteissä on osoitettu eristämällä kyseinen mikrobi. Rikastuskasvatuksen jälkeen mikrobi on tunnistettu joko biokemiallisten ominaisuuksiensa perusteella tai immunologisin menetelmin. Tällainen diagnostiikka 20 edellyttää, että näytteessä oleva mikrobi on lisääntymiskykyinen. Eristämisen kautta tapahtuva tunnistus on lisäksi työläs menetelmä, joka,virusten kyseessä ollen saattaa kestää 4-6 viikkoa.15 In traditional microbial diagnostics, the presence of a microbe in test samples has been demonstrated by isolating the microbe in question. After enrichment culture, the microbe is identified either by its biochemical properties or by immunological methods. Such diagnostics 20 require that the microbe in the sample be reproducible. In addition, detection through isolation is a laborious method which, in the case of viruses, may take 4 to 6 weeks.
25 Keksinnön tarkoituksena on aikaansaada diagnostinen menetelmä, jossa mikrobin läsnäolo näytteessä osoitetaan tunnistamalla sen perintöaines, nukleiinihappo, herkän ja spesifisen nukleiinihappohybridisaation avulla. Nukleiinihappohybridisaatio sinänsä on vanha ja tunnettu 30 menetelmä nukleiinihappojen identiteettiä tutkittaessa. Vastakkaismerkkisillä nukleiinihapposäikeillä on kyky muodostaa tiukka kaks isäikeinen rakenne vastinemästen pariutumissäännön perusteella, ja syntynyt hybridi voidaan erottaa yksisäikeiseksi jääneestä nukleiini-35 haposta.It is an object of the invention to provide a diagnostic method in which the presence of a microbe in a sample is detected by identifying its genome, nucleic acid, by sensitive and specific nucleic acid hybridization. Nucleic acid hybridization per se is an old and known method for studying the identity of nucleic acids. Opposite-branded nucleic acid strands have the ability to form a tight two-stranded structure based on the mating rule of the counterparts, and the resulting hybrid can be distinguished from the single-stranded nucleic acid.
2 635962 63596
Nukleiinihapon tunnistukseen perustuvia menetelmiä on tähän mennessä sovellettu mikrobidiagnostiikkaan jonkin verran. Enterotoksigeeninen E. coli -bakteeri on osoitettu ulostenäytteistä pesäkehybridisaation avulla 5 käyttäen koettimena toksiinin tuotosta vastaavaa geeniä.Methods based on nucleic acid identification have so far been applied to microbial diagnostics to some extent. Enterotoxigenic E. coli has been detected in faecal samples by colony hybridization 5 using the gene responsible for toxin production as a probe.
Positiivinen hybridisaatio havaitaan autoradiografiän avulla (Moseley, S.L. et ai. J. Infect. Dis. (1980) 142, 892 - 898). Pesäkehybridisaatio perustuu alun-10 perin Grunsteinin ja Hognessin kehittämään menetelmään (Proc. Natl. Acad. Sei. USA (1975) 72, 3961 - 3965). Lisäksi hybridisaatiota on sovellettu Herpes simplex 1 ja Herpes simplex 2 -virusten erottamiseen toisistaan (Brautigam A.R. et ai. J. Clin. Microbiol. (1980) 12, 15 226 - 234), ei kuitenkaa pikadiagnostisena menetelmänä vaan rikastekasvatuksen jälkeen virusta tyypitettäessä. Tässä menetelmässä liukoinen kaksisäikeinen hybridi erotetaan yksisäikeiseksi jääneestä affiniteetti-kromatografiän avulla.Positive hybridization is detected by autoradiography (Moseley, S.L. et al. J. Infect. Dis. (1980) 142, 892-898). Colony hybridization is based on the method originally developed by Grunstein and Hogness (Proc. Natl. Acad. Sci. USA (1975) 72, 3961-3965). In addition, hybridization has been applied to distinguish between Herpes simplex 1 and Herpes simplex 2 viruses (Brautigam A.R. et al. J. Clin. Microbiol. (1980) 12, 15226-234), but not as a rapid diagnostic method but after concentrate culture in virus typing. In this method, a soluble double-stranded hybrid is separated from single-stranded hybrid by affinity chromatography.
2020
Hiljattain on tehty työ, jossa Epstein-Barr-viruksella infektoiduista soluista peräisin oleva DNA, ts. näyte, tiettyjen käsittelyjen jälkeen on suoraan kiinnitetty filttereille. Kyseinen nukleiinihappo tunnistetaan 25 hybridisoimalla filtterit radioaktiivisen koettimen läsnäollessa ja positiivinen hybridisaatio detektoidaan autoradiografiän avulla (Brandsma, I. & Miller, K. (1980) Proc. Natl. Acad. Sei. USA 77, 6851 - 6855).Recently, work has been done in which DNA from cells infected with Epstein-Barr virus, i.e., a sample, is directly attached to filters after certain treatments. The nucleic acid in question is identified by hybridizing the filters in the presence of a radioactive probe and positive hybridization is detected by autoradiography (Brandsma, I. & Miller, K. (1980) Proc. Natl. Acad. Sci. USA 77, 6851-6855).
30 Julkaisussa the Lancet 10 Det., ss. 765 - 7, 1982 esitetään samantapainen menetelmä, jossa radioaktiivisesti leimatulla koettimella osoitetaan hepatitis B-virus näytteestä, jonka DNA on saatettu yksisäikeiseksi ja on kiinnitetty nitroselluloosafiltteriin. Hakemusjulkaisussa 35 DE 2950295 kuvataan tällaisen hepatitis B-viruksen radioaktiivisella merkkiaineella varustetun koettimen valmistusmenetelmä yhdistelmä-DNA-tekniikkaa hyväksikäyttäen.30 In the Lancet 10 Det., P. 765-7, 1982 discloses a similar method in which a radiolabeled probe detects hepatitis B virus from a sample whose DNA has been made single-stranded and attached to a nitrocellulose filter. DE 2950295 describes a method for the preparation of such a hepatitis B virus radiolabeled probe using recombinant DNA technology.
3 635963 63596
Keksintömme mukaisessa menetelmässä käytetään sarjaa rea~ genssien yhdistelmiä, jotka koostuvat vähintään kahdesta erilaisesta nukleiinihapporeagenssista, jotka on valmistettu saman mikrobin tai mikrobiryhmän genomin eri osista.The method of our invention uses a series of combinations of reagents consisting of at least two different nucleic acid reagents prepared from different parts of the genome of the same microbe or group of microbes.
5 Näistä nukleiinihapporeagensseista toinen on sidottu kiinteään kantajaan ja toinen on leimattu merkkiaineella.5 Of these nucleic acid reagents, one is bound to a solid support and the other is labeled with a label.
Näiden kahden nukleiinihapporeagenssin avulla voidaan suoraan näytteestä, jonka DNA on saatettu yksisäikeiseksi, osoittaa kaikki mikrobit ja mikrobiryhmät, joita varten 10 on valmistettu reagensseja. Keksintömme mukaisen kahdesta reagenssista koostuvan sarjan käyttö tekee diagnostisoimis-menetelmän huomattavasti spesifisemmäksi kuin edellä kuvattu menetelmä ja mahdollistaa myös erilaisten kitti-yhdistelmien rakentamisen ja samanaikaisen käytön ilman 15 että nämä reagenssit häiritsevät toisiaan ja testin spesifisyyttä .These two nucleic acid reagents can be used to directly detect all microbes and groups of microbes for which reagents have been prepared from a single-stranded DNA sample. The use of a kit of two reagents according to our invention makes the diagnostic method considerably more specific than the method described above and also allows the construction and simultaneous use of different kit combinations without interfering with each other and the specificity of the test.
Käsiteltävänä oleva keksintö perustuu kerroshybridisaa-tiotekniikkaan (Dunn, A.R. & Hassell, 3.A. (1977) Cell 12, 20 23 - 36), jonka ansiosta näytteen käsittely ja hybridin detektio saadaan yksinkertaiseksi. Tämän takia tekniikka soveltuu erinomaisen hyvin diagnostiseen käyttöön.The present invention is based on the layer hybridization technique (Dunn, A.R. & Hassell, 3.A. (1977) Cell 12, 20 23-36), which simplifies sample handling and hybrid detection. For this reason, the technology is excellently suited for diagnostic use.
Keksinnön mukaisessa menetelmässä yhdestä ja samasta 25 näytteestä, joka sisältää diagnostisoitavien mikrobien tai mikrobiryhmien yksisäikeiseksi saatettuja nukleiinihappoja, voidaan sitä jakamatta tunnistaa kaikki halutut mikrobit tai mikrobiryhmät lisäämällä näytteeseen jokaista tunnistettavaksi tarkoitettua mikrobia tai mikrobiryhmää 30 kohden kaksi nukleiinihapporeagenssia. Nämä nukleiini-happoreagenssit sisältävät samasta mikrobista tai 63596 mikrobiryhmästä peräisin olevat keskenään täysin erilaiset mutta edullisesti toistensa lähettyvillä sijainneet nukleiinihappo-fragmentit, jotka voidaan valmistaa joko suoraan mikrobigenomista tai sinänsä tunnettua yhdistelmä-QNA-5 tekniikkaa hyväksi käyttäen ja näistä nukleiinihappo- fragmenteista toinen on saatettu yksisäikeiseksi ja kiinnitetty kiinteään kantajaan edullisesti nitroselluloosa-filtterille ja toinen on saatettu yksisäikeiseksi ja leimattu jollakin menetelmään soveltuvalla merkkiaineella. 10 Kun nämä nukleiinihapporeagenssit, kaksi erilaista jokaista tunnistettavaksi tarkoitettua mikrobia tai mikrobi-ryhmää kohden, saatetaan kosketukseen näytteessä olevien tunnistettavaksi tarkoitettujen yksisäikeisten nukleiinihappojen kanssa, nämä nukleiinihapot sitoutuvat kiinteällä 15 kantajalla oleviin vastaaviin tunnistaviin nukleiinihappo-fragmentteihin ja muodostuneet kiinteällä kantajalla olevat hybridit leimautuvat vastaavien leimattujen nukleiinihappo-fragmenttien avulla. Nämä leimatut nukleiinihappofragmen-tit eivät yksin hybridisoidu kiinteällä kantajalla oleviin 20 nukleiinihappofragmentteihin vaan näytteestä peräisin oleviin yksisäikeisiin nukleiinihappoihin. Tällöin ainoastaan ne kiinteät kantajat, joihin on sitoutunut näytteessä olevia vastaavia nukleiinihappoja, leimautuvat, ja nämä kiinteät kantajat voidaan huuhtoa ja leimaus mitata sinänsä 25 tunnetuin menetelmin.In the method of the invention, all desired microbes or microbial groups can be identified without dividing from one and the same sample containing nucleic acids of single-stranded microbes or microbial groups to be diagnosed by adding two nucleic acid reagents for each microbial or microbial group to be identified. These nucleic acid reagents contain completely different but preferably closely spaced nucleic acid fragments from the same microbe or 63596 microbial clusters, which can be prepared either directly from the microbial genome or by recombinant QNA-5 techniques known per se, and one of these nucleic acid fragments is isolated. and attached to a solid support, preferably a nitrocellulose filter, and the other is monofilamented and labeled with a label suitable for the method. When these nucleic acid reagents, two different for each microbial or group of microbes to be identified, are contacted with the single-stranded nucleic acids to be identified in the sample, these nucleic acids bind to the corresponding nucleic acid fragments on the solid support. fragments. These labeled nucleic acid fragments alone do not hybridize to solid support nucleic acid fragments but to single-stranded nucleic acids from a sample. In this case, only those solid supports to which the corresponding nucleic acids in the sample are bound are labeled, and these solid supports can be rinsed and the labeling measured by methods known per se.
Keksinnön mukaista menetelmää voidaan periaatteessa käyttää kaikkien nukleiinihappoja, joko DNA:ta tai RNA:ta sisältävien organismien kuten esimerkiksi virusten, bakteerien, 30 homeiden ja hiivojen tunnistamiseksi. Tämän menetelmän erityisetuna voidaan pitää sitä, että samasta näytteestä voidaan yhtäaikaisesti tutkia kaikkien kyseeseen tulevien sekä bakteerien että virusten läsnäolo riippumatta siitä sisältävätkö mikrobit DNArta tai RNA:ta. Reagensseja 35 yhdistelemällä voidaan ts. rakentaa "kitti”-kokonaisuuksia siten, että kutakin tunnistettavaa mikrobia varten on oma 5 63596 tunnuksella varustettu kiinteä kantajansa ja merkkiaineella varustettu nukleiinihapporeagenssinsa. Näytteeseen voidaan lisätä kaikki reagenssien yhdistelmään kuuluvat filtterit yhdellä kertaa, samoin leimatut nukleiinihappo-5 reagenssit. Kun hybridisaatio on tapahtunut, kiinteät kantajat pestään ja leimautuminen mitataan. Ainoastaan oikea kiinteä kantaja tulee leimatuksi eli se jota vastaava mikrobigenomi oli näytteessä.The method according to the invention can in principle be used for the identification of all organisms containing nucleic acids, either DNA or RNA, such as, for example, viruses, bacteria, molds and yeasts. A particular advantage of this method is that the same sample can be tested simultaneously for the presence of all relevant bacteria and viruses, regardless of whether the microbes contain DNA or RNA. That is, by combining the reagents 35, "kit" assemblies can be constructed so that each identifiable microbe has its own solid support and labeled nucleic acid reagent with 5,63596. All filters in the reagent combination can be added to the sample at once, as well as labeled nucleic acid reagents. Once hybridization has taken place, the solid supports are washed and labeling is measured, and only the correct solid support is labeled, i.e. the one with the corresponding microbial genome in the sample.
10 Menetelmää ja sarjaa reagenssien yhdistelmiä voidaan käyttää mm. lääketieteellisessä mikrobiologiassa, eläinlääketieteellisessä mikrobiologiassa, elintarvikehygienisissä tutkimuksissa sekä kasvitautien mikrobidiagnostiikassa. Näytteeksi kelpaavat kaikki eläin- tai kasvikudoksesta 15 peräisin olevat homogenaatit, potilaseritteet kuten veri, uloste, nenänielu- ja uretralima. Voidaan arvioida, että menetelmä on riittävän herkkä osoittamaan kliinisissä näytteissä normaalisti esiintyvät mikrobimäärät. Näytteessä olevan mikrobin esirikastus viljelyn avulla on 20 luonnollisesti mahdollista ennen tunnistustestin suorittamista ja joissakin tapauksissa se on suorastaan välttämätöntä. Menetelmä soveltuu myös sellaisten näytteiden tutkimiseen, joista mikrobi ei ole enää viljeltävissä, mutta mikrobin osia on vielä runsaasti näytteessä 25 (esim. antibioottihoito on aloitettu) tai mikrobin viljely on erityisen työläs ja vaikea toimenpide (esim. anaerobiset bakteerit, joita kuitenkin on runsaasti märkänäytteissä, kun kyseessä on anaerobin aiheuttama infektio).10 The method and a series of combinations of reagents can be used e.g. in medical microbiology, veterinary microbiology, food hygiene research and microbial diagnostics of plant diseases. All homogenates from animal or plant tissue, patient secretions such as blood, faeces, nasopharynx and urethral mucus are suitable as samples. It can be estimated that the method is sensitive enough to detect microbial counts normally present in clinical specimens. Pre-enrichment of the microbe in the sample by culture is, of course, possible before performing the identification test and in some cases it is absolutely necessary. The method is also suitable for examining samples from which the microbe is no longer cultured but the microbial constituents are still abundant in the sample (eg antibiotic treatment has been started) or microbial culture is a particularly laborious and difficult procedure (eg anaerobic bacteria abundant in wet samples). in the case of anaerobic infection).
3030
Menetelmää voidaan soveltaa kliinisen lääketieteen ja elintarvikehygienian mikrobidiagnostiikassa esim. seu-raavien mikrobien tai mikrobiryhmien tunnistamiseen.The method can be applied in microbial diagnostics of clinical medicine and food hygiene, e.g. to the identification of the following microbes or groups of microbes.
66
Respiratoriset infektiot: 63596 a) Bakteerit: ^-hemolyyttinen streptococci, (A-ryhmä), Haemophilus influenzae. Pneumococci, Mycoplasma 5 pneumoniae, mykobakteerit b) Virukset: Influenza A, Influenza B, Parainfluenssa 1-3, Respiratory syncytial virus, adenovirukset, coronavirukset, rhinovirukset 10Respiratory infections: 63596 a) Bacteria: ^ -hemolytic streptococci, (group A), Haemophilus influenzae. Pneumococci, Mycoplasma 5 pneumoniae, mycobacteria b) Viruses: Influenza A, Influenza B, Parainfluenza 1-3, Respiratory syncytial virus, adenoviruses, coronaviruses, rhinoviruses 10
Ripulit: a) Bakteerit: Salmonella, Shigella, Yersinia entero-colitica, enterotoxigeeninen E. coli, Clostridium 15 di fficile, campylobakteerit b) Virukset: rotavirukset, parvovirukset, adenovirukset, enterovirukset 20 Sukupuolitaudit: a) Bakteerit: Neisseria gonorrhoeae, Treponema pallidum. Chlamydia trachomatis 25 b) Virukset: Herpes simplex -virus c) Hiivat: Candida albicans d) Alkueläimet: Trichomonas vaginalis 30Diarrhea: a) Bacteria: Salmonella, Shigella, Yersinia entero-colitica, enterotoxigenic E. coli, Clostridium 15 di fficile, campylobacter b) Viruses: rotaviruses, parvoviruses, adenoviruses, enteroviruses 20 Sexually transmitted diseases: a) Bacteria: Neisseria gonorrhoea Chlamydia trachomatis 25 b) Viruses: Herpes simplex virus c) Yeasts: Candida albicans d) Protozoa: Trichomonas vaginalis 30
Sepsis : a) Bakteerit: yj-hemolyyttinen streptococci, (A-ryhmä), Pneumococci, enterobakteerit ryhmänä 7 63596Sepsis: a) Bacteria: γ-hemolytic streptococci, (group A), Pneumococci, enterobacteria as group 7 63596
Elintarvi kehygienia: a) Bakteerit: salmonellat ja Clostridium perfringens 5 Riippuen reagenssien valinnasta testin spesifiteetti voidaan rajata mikrcbikohtaiseksi (esim. salmonellat) tai valitsemalla tunnistavat reagenssit kokonaiselle mikrobi-ryhmälle yhteisen geenin alueelta voidaan tunnistaa esimerkiksi koko enterobakteeriryhmä.Food hygiene: (a) Bacteria: Salmonella and Clostridium perfringens 5 Depending on the choice of reagents, the specificity of the test may be limited to microbes (eg salmonella) or by selecting recognizing reagents for an entire microbial group from a common gene region.
1010
Keksinnön mukaisessa kerroshybridisaatiotekniikassa tarvittavat nukleiinihapporeagenssit tuotetaan yhdistelmä-DNA-tekniikan avulla. Seuraavassa kuvataan esimerkki 1:ta varten tuotetut reagenssit ja testin suoritus.The nucleic acid reagents required in the layer hybridization technique of the invention are produced by recombinant DNA technology. The reagents produced for Example 1 and the performance of the test are described below.
1515
Reagenssitreagents
Adenovirus 2 (kanta säilytetty KTLsssä eli Kansanterveyslaitoksessa Helsingissä) kasvatetaan ja puhdistetaan 20 ja DNA eristetään (Petterson, U. & Sambrook, J. (1973) J. Mol. Biol. _73, 125 - 130) (kutsutaan Ad2-DNA: ksi) .Adenovirus 2 (strain stored in KTL, i.e. the Public Health Institute in Helsinki) is grown and purified and DNA is isolated (Petterson, U. & Sambrook, J. (1973) J. Mol. Biol. 73, 125-130) (referred to as Ad2 DNA). .
DNA hajotetaan BamHI - restriktioentsyymillä (BRL eli Bethesda Research Laboratories), joka katkaisee DNA:n neljään aina samanlaiseen fragmenttiin. Näistä neljästä 25 kaksi fragmenttia liitetään vektoriksi valitun pBR322-plasmidin (BRL) BamHI-katkaisukohtaan T4-ligaasientsyymin (BRL) avulla. (Fragmentteja ei erotettu toisistaan ennen ligaatiota, vaan plasmidin kulloinkin saama lisä - eli insertti - tunnistetaan vasta kloonauksen jälkeen.) 30 Tämän jälkeen plasmidi-DNA, jonka joukossa nyt on myös niin kutsuttuja rekombinanttiplasmideja eli sellaisia molekyylejä, jotka ovat hyväksyneet adenoviruksen DNA-jaksoja osikseen toivotulla tavalla, siirretään bakteeri - isäntään (E. coli HB101 (K12)(ga1 , pro , leu , hrs , hrm~, recA, 35 str , F )(KTL:Stä) transformaation avulla (Cohen, S.N. et ai. (1972) Proc. Natl. Acad. Soi. USA 69, 2110 - 2114). Transformoituneiden bakteerikloonien joukosta valitaan sellaiset, jotka todennäköisimmin sisältävät rekombi-nantti-plasmidin. Bakteeri saa pBR322-plasmidilta sekä __ - 1,.. .... - β 63596 ampisilliini- että tetrasykliiniresistenssigeenit (Bolivar, F. et ai. ( 1977) Gene £, 95-113). Rekombinanttiplasmidia sisältävät bakteerit taas ovat tetrasykliinilie herkkiä, koska BamHI-entsyymi katkaisee plasmidi-DNA:n tetrasyk-5 liiniresistenssigeenin alueelta ja tälle alueelle liittyvä vieras DNA tuhoaa geenin. Plasmidin saama insertti karakterisoidaan plasmidirikastuksen jälkeen BamHI-digestion avulla määrittämällä insertin koko agaroosigeelielektro-foreesin avulla. Reagensseiksi valitaan vierekkäiset 10 Ad2~DNA:n BamHI D- ja C-fragmentit (vrt. geenikartta), (Söderlund, H. et ai. ( 1976) Cell 7, 585 - 593). Oikeat, rekombinanttiplasmidit, Ad2C-pBR322, KTL n:oEH231 ja Ad2D-pBR322, KTL n:o EH230, kasvatetaan ja puhdistetaan kuten on kuvattu (Clewell, D.B. and Helinski, D.R. (1969) 15 Proc. Natl. Acad. Sei. USA 62, 1159 - 1166).The DNA is digested with the restriction enzyme BamHI (BRL, or Bethesda Research Laboratories), which cleaves the DNA into four identical fragments. Of these four, two fragments are ligated to the BamHI cleavage site of the vector selected as the vector pBR322 (BRL) using the T4 ligase enzyme (BRL). (The fragments were not separated before ligation, but the additional insert received by the plasmid - i.e. the insert - is not identified until after cloning.) Then plasmid DNA, which now includes so-called recombinant plasmids, i.e. molecules that have accepted adenovirus DNA sequences as part of it. as desired, is transferred to a bacterial host (E. coli HB101 (K12) (ga1, pro, Leu, hrs, hrm ~, recA, 35 str, F) (from KTL) by transformation (Cohen, SN et al. (1972 ) Proc. Natl. Acad. Soi. USA 69, 2110-2114) Among the transformed bacterial clones, those most likely to contain the recombinant plasmid are selected, the bacterium obtains from plasmid pBR322 and __ - 1, .. .... - β 63596 ampicillin and tetracycline resistance genes (Bolivar, F. et al. (1977) Gene®, 95-113) Bacteria containing the recombinant plasmid, on the other hand, are sensitive to tetracycline because the BamHI enzyme cleaves the tetracycline resistance of plasmid DNA. from the region and the foreign DNA associated with that region destroys the gene. The insert obtained by the plasmid is characterized after plasmid enrichment by BamHI digestion by determining the size of the insert by agarose gel electrophoresis. Adjacent BamHI D and C fragments of 10 Ad2 DNA (cf. gene map) are selected as reagents (Söderlund, H. et al. (1976) Cell 7, 585-593). The correct recombinant plasmids, Ad2C-pBR322, KTL No. EH231 and Ad2D-pBR322, KTL No. EH230, are grown and purified as described (Clewell, DB and Helinski, DR (1969) 15 Proc. Natl. Acad. Sci. USA). 62, 1159 - 1166).
Rekombinanttiplasmidi Ad2D-pBR322 käytetään sellaisenaan filtterireagenssiksi. Plasmidisekvenssejä ei tätä tarkoitusta varten tarvitse poistaa, koska näytteessä ei ole 20 pBR322-sekvenssejä. Sen sijaan radioaktiiviseksi leimattava nukleiinihapporeagenssi Ad2_BamHI C-fragmentti erotetaan pBR322-DNA:sta BamHI-digestion jälkeen agaroosi-geelielektroforeesin avulla. C-fragmentti eristetään LGT-agarase (Marine Colloids, Inc.) -geelistä fenoli-25 ekstraktion tai elektroeluution avulla (Wieslander, L.The recombinant plasmid Ad2D-pBR322 is used as such as a filter reagent. Plasmid sequences do not need to be deleted for this purpose because there are no 20 pBR322 sequences in the sample. Instead, the radiolabeled nucleic acid reagent Ad2_BamHI C fragment is separated from pBR322 DNA after BamHI digestion by agarose gel electrophoresis. The C fragment is isolated from an LGT agarase (Marine Colloids, Inc.) gel by phenol-25 extraction or electroelution (Wieslander, L.
( 1979) Anal. Biochem. 9_8, 305 - 309) ja konsentroidaan saostamalla etanolilla.(1979) Anal. Biochem. 9_8, 305-309) and concentrated by precipitation with ethanol.
Leimatuksi nukleiinihapporeagenssiksi valittava nukleiini-30 happofragmentti on erittäin tarkoituksenmukaista edelleen kloonata toiseen vektoriin, jolloin päästään eroon hybridisaatio taustasta, mikä johtuu leimattuun nukleiinihappo-reagenssiin epäpuhtautena jääneiden plasmidijaksojen suorasta hybridisaatiosta filtteriin. Tällainen opti-35 maalinen toinen vektori on yksisäikeinen DNA-faagi M13 mp7 (BRL), johon on helppo siirtää esimerkiksi BamHI-entsyymin avulla aikaansaatuja DNA-fragmentteja (Messing, 0. et ai.It is highly convenient to further clone the nucleic acid fragment to be selected as the labeled nucleic acid reagent into another vector to eliminate hybridization from the background due to direct hybridization to the filter of plasmid sequences remaining contaminated in the labeled nucleic acid reagent. One such second optical vector is the single-stranded DNA phage M13 mp7 (BRL), to which DNA fragments obtained, for example, by the BamHI enzyme are easily transferred (Messing, 0. et al.
(1981) Nucleic Acids Res. £, 309 - 323).(1981) Nucleic Acids Res. £, 309 - 323).
9 DNA:n kiinnitys filtterille 635969 Attachment of DNA to filter 63596
Rekombinanttiplasmidi Ad2Ö-pBR322 denaturoidaan yksisäi-keiseksi ja katkotaan sokeasti muutamasta kohdasta 0.2 N 5 NaOH-käsittelyllä (5 min 100°C), jonka jälkeen DNA jäähdytetään ja juuri ennen filtterille siirtoa neutraloidaan ja pipetoidaan siirtoliuokseen 4 x SSC -mediumiin jäillä (SSC = 0.15 M NaCl, 0.015 Π Na-sitraatti). Filtterit (Schleicher & Schull ΒΑΘ5 ni troselluloosa) kostutetaan 10 huolella 4 x SSC -liuoksessa (noin 2 t) ennen DNA-apli-kaatiota. DNA tartutetaan filtterille laimeassa liuoksessa (0.5 - 1 /ug/ml) suodattamalla liuos filtterin läpi lievässä vesi-imussa, jolloin DNA tarttuu. Filtteri kykenee sitomaan 0NA:ta noin 1Θ0 jug/cm (Kafatos, F.C.The recombinant plasmid Ad2Ö-pBR322 is denatured into a single strand and cleaved blindly at a few sites by 0.2 N 5 NaOH treatment (5 min at 100 ° C), after which the DNA is cooled and neutralized and pipetted into the transfer solution 4 x SSC medium on ice (SSC = 0.15) just before transfer to the filter. M NaCl, 0.015 Π Na citrate). Filters (Schleicher & Schull ΒΑΘ5 ni cellulose) are carefully wetted in 4 x SSC solution (approximately 2 h) before DNA application. The DNA is adhered to the filter in a dilute solution (0.5 to 1 ug / ml) by filtering the solution through the filter under gentle water suction, whereby the DNA adheres. The filter is capable of binding 0NA at about 1Θ0 μg / cm (Kafatos, F.C.
15 et ai. ( 1979] Nucleic Acids Research 7_, 1541 - 1552). Käytetään DNA-konsentraatioita 0.5 yug DNA:ta/ 2.5 cm halkaisijaltaan oleva filtteri aina 1 yugraan DNA:ta/7 mm halkaisijaltaan oleva filtteri. DNA-suoda-tuksen jälkeen filtterit pestään 4 x SSC:llä, kuivataan 20 huoneen lämmössä ja viimeksi käsitellään +80-asteisessa vakuumiuunissa 2 h, jonka jälkeen DNA säilyy niissä vakaana ja filtterit voidaan säilyttää huoneen lämmössä pitkiä aikoja (Southern, E.M. (1975) 0. Mol. Biol. 96, 503 - 51 7) .15 et al. (1979] Nucleic Acids Research 7, 1541-1552). DNA concentrations of 0.5 μg DNA / 2.5 cm diameter filter up to 1 μg DNA / 7 mm diameter filter are used. After DNA filtration, the filters are washed 4x with SSC, dried at 20 room temperature and last treated in a +80 ° C vacuum oven for 2 h, after which the DNA remains stable and the filters can be stored at room temperature for long periods (Southern, EM (1975)). 0. Mol Biol 96, 503 - 51 7).
2525
Radioaktiivisen nukleiinihappofragmentin leimaus 125Labeling of a radioactive nucleic acid fragment 125
Radioaktiivisena leimana käytetään I-isotooppia .The I isotope is used as the radiolabel.
30 Tämä on detektoitavissa Y~laskijalla, joka on olemassa useimmissa suurissa laboratorioyksiköissä. Isotoopin puoliintumisaika on 60 päivää, jonka takia tällä leimattujen reagenssien käyttöaika on noin 4 kk.30 This is detectable with the Y ~ counter that exists in most large laboratory units. The half-life of the isotope is 60 days, which is why the shelf life of the reagents labeled with this is about 4 months.
1 G1 G
63596 "Nie k-translation”-leimaus63596 “Nie k-translation” stamp
Menetelmän ideana on vaihtaa jokin nukleiinihapon nukleotideista radioaktiiviseksi , jolloin samalla koko DNA leimautuu. 5 Tämä tapahtuu Rigby, P.W.3. et al.:n (1977) 3. Mol. Biol. 113, 237 - 251) julkaiseman menetelmän mukaisesti. Reaktiossa DNA leimautuu radioaktiiviseksi, kun liuoksessa on 125 raaka-aineena I-isotoopi 11a leimattu dedksinukleosidi- 125 trifosfaatti, tässä tapauksessa I-dCTP (Radiochemical 10 Centre, Amersham: >1500 Ci/mmol). Optimaalisissa olo- 9 suhteissa DNA:han saadaan leimaa jopa 10 cpm yug DNA:ta kohti. Leimattu DNA puhdistetaan reaktiossa vapaaksi jääneistä nukleotideista yksinkertaisen geelisuodatuksen avulla, esim. käyttämällä BioGel P30:tä (BioRad).The idea of the method is to change one of the nucleotides of the nucleic acid to radioactive, at the same time labeling all the DNA. 5 This occurs in Rigby, P.W.3. et al. (1977) 3. Mol. Biol. 113, 237-251). In the reaction, the DNA is radiolabeled when the solution contains 125 I-isotope-labeled dedxinucleoside triphosphate as raw material, in this case I-dCTP (Radiochemical Center 10, Amersham:> 1500 Ci / mmol). Under optimal conditions, up to 10 cpm of DNA per DNA can be labeled. Labeled DNA is purified from nucleotides released in the reaction by simple gel filtration, e.g., using BioGel P30 (BioRad).
1515
Muu leimausOther stamping
Yksisäikeinen M13 mp7-faagissa tuotettava nukleiinihappo- 20 reagenssi on tarkoituksenmukaista leimata suoran jodee- 125 rauksen avulla, jolloin reaktiivinen I liitetään kova-lentisti nukleiinihappoon (Commerford, S.L. (1971) Biochemistry _1_0, 1993 - 2000, Orosz, J.M. and Wetmur, 3.G.The single-stranded nucleic acid reagent produced in M13 mp7 phage is conveniently labeled by direct iodination, with reactive I being hard-ligated to the nucleic acid (Commerford, SL (1971) Biochemistry _1_0, 1993-2000, Orosz, JM and Wetmur, 3). G.
( 1974) Biochemistry j_3, 5467 - 5473). Vaihtoehtoisesti 25 nukleiinihappo voidaan saattaa radioaktiiviseksi liittämällä sen päihin radioaktiivinen nukleotidi terminaalisen transferaasin avulla (Roychoudhury, R. and Wu, R. (19B0) Meth. Enzymol. 6_5, 43 - 62).(1974) Biochemistry j_3, 5467-5473). Alternatively, the nucleic acid can be radioactivated by attaching a radioactive nucleotide to its ends by terminal transferase (Roychoudhury, R. and Wu, R. (19B0) Meth. Enzymol. 6_5, 43-62).
30 Edellä käsitelty reagenssivalmistus koskee sellaisia mikrobeja, joiden perintöaines on DNA:ta. RNA-viruksien genomifragmenttien kloonaus tapahtuu siten, että ensin tehdään virus RNA:sta DNA-kopio (cDNA) reverse transkrip-taasientsyymin avulla, jonka jälkeen DNA-polymeraasi saat-35 taa DNA:n kaksisäikeiseksi ja DNA on kloonattavissa kuten yllä on esitetty (Salser, W. (1979) in Genetic Engineering, Ed. A.M. Chakrabarty, CRC Press, pp. 53 - 81).30 The reagent preparation discussed above concerns microbes whose genetic material is DNA. Cloning of RNA virus genomic fragments is accomplished by first making a DNA copy (cDNA) of the viral RNA using a reverse transcriptase enzyme, after which the DNA polymerase renders the DNA double-stranded and the DNA can be cloned as described above (Salser , W. (1979) in Genetic Engineering, Ed. AM Chakrabarty, CRC Press, pp. 53-81).
11 6359611 63596
Kunkin mikrobin kohdalla käytetään mahdollisimman tarkoituksenmukaista kloonausmenetelmää, jossa käytettävä vektori sekä isäntä voivat vaihdella. Kyseeseen voivat tulla λ-faagi vektorina, muut plasmidit, kosmidit, kloonaus 5 mm. Bacillus subtilis -bakteerissa jne. (Recombinant DNA, Benchmarck Papers in Microbiology, Voi. 15, Ed. K.3. Denniston & L.W. Enqvist, Dowden, Hutchinson & Ross, Inc. (19BDj Ish-Horowicz, D. and Burke, 3.F. (19813 Nucleic Acids Research j), 2989 - 29983 .For each microbe, the most appropriate cloning method is used, in which the vector used and the host may vary. Possible λ-phage vector, other plasmids, cosmids, cloning 5 mm. In Bacillus subtilis, etc. (Recombinant DNA, Benchmarck Papers in Microbiology, Vol. 15, Ed. K.3. Denniston & LW Enqvist, Dowden, Hutchinson & Ross, Inc. (19BDj Ish-Horowicz, D. and Burke, 3 .F (19813 Nucleic Acids Research j), 2989 - 29983.
1010
Testin suoritus Näytekäsittely 15Test performance Sample handling 15
Tutkittava mikrobinukleiinihappo on vapautettava sekä mikrobin sisältä että infektoiduista soluista ja denaturoitava yksisäikeiseen muotoon. Virusgenomit saadaan vapautetuiksi käsittelemällä näytemateriaali 1 %:sella nat-20 riumdodekyylisulfaattiliuoksella (SDS) ja hajottamalla niitä suojaavat proteiinit proteinaasi-K-käsittelyllä (1 mg/ml +37°, 60 min). Bakteerinäyte on näiden lisäksi hajotettava lysotsyymi- ja EDTA-käsittelyin .The microbinucleic acid to be examined must be released both inside the microbial and from the infected cells and denatured into a single-stranded form. Viral genomes are released by treating the sample material with 1% sodium dodecyl sulfate solution (SDS) and degrading their protective proteins by proteinase K treatment (1 mg / ml + 37 °, 60 min). In addition, the bacterial sample must be digested with lysozyme and EDTA.
25 3os näyte sisältää runsaasti sitkeää jättiläiskokoista solu-DNA:ta, tätä on katkottava sieltä täältä viskositeetin alentamiseksi esim. sonikoimalla tai puristamalla näyte ohuen neulan läpi muutamia kertoja.25 The 3s sample contains a lot of tough giant cellular DNA, this must be cut from here to here to reduce the viscosity, e.g. by sonicating or squeezing the sample through a thin needle a few times.
3030
Hybridisaatiohybridization
Hybridisaatio tapahtuu esimerkiksi 50 %:sessa formami-dissa (deionisoitu, säilytetty -20°C:ssa), 4 x SSC:ssä, 1 x 35 Denhardtin liuoksessa (Denhardt, D.T. (1966) Biochem.Hybridization occurs, for example, in 50% formamide (deionized, stored at -20 ° C), 4 x SSC, 1 x 35 Denhardt's solution (Denhardt, D.T. (1966) Biochem.
Biophys. Res. Commun. 2_3, 641 - 646), jossa on 1 % SDS sää ja 0,5 mg/ml DNAsta (salmon sperm tai calf thymus) +37°C:ssa 12 63596 yleensä yli yön 16 - 20 tuntia. Testiin valitut filtterit inkuboidaan sopivassa astiassa, johon pipetoidaan hybridi* saatioliuos ja hybridisaatio aloitetaan. Hybridisaatio* liuos koostuu (a) esikäsitellystä näytteestä ja tähän yhdis* 5 tetystä radioaktiivisesta nukleiinihapporeagenssista/rea* gensseista, jotka on denaturoitu keittämällä 5 minuuttia, jonka jälkeen liuos on nopeasti jäähdytetty 0°C:een; (b) konsentroiduista formamidi-, SSC- ja Denhardt*liuoksista, jotka pipetoidaan denaturoituun ja jäähtyneeseen 10 seokseen (a). Sekoituksen jälkeen hybridisaatioliuos pipetoidaan hybridisaatioastiaan filttereille. Hybridi* saation jälkeen filtterit pestään huolellisesti ja filtterit lasketaan yksitellen V-laskijassa.Biophys. Res. Commun. 2, 641-646) with 1% SDS weather and 0.5 mg / ml DNA (salmon sperm or calf thymus) at + 37 ° C 12,63596, usually overnight for 16-20 hours. The filters selected for the test are incubated in a suitable vessel into which the hybrid * solution is pipetted and hybridization is started. The hybridization * solution consists of (a) a pretreated sample and associated radioactive nucleic acid reagent (s) denatured by boiling for 5 minutes, after which the solution is rapidly cooled to 0 ° C; (b) concentrated formamide, SSC and Denhardt * solutions pipetted into the denatured and cooled mixture (a). After mixing, the hybridization solution is pipetted into the hybridization vessel for filters. After hybridization, the filters are washed thoroughly and the filters are counted one by one in a V-counter.
15 Keksintö selvennetään vielä muutamalla käyttöesimerkillä.The invention is further clarified by a few examples of use.
Esimerkki 1Example 1
Adenoviruksen detektio kerroshybridisaatio-menetelmän 20 avulla (Taulukko 1)Detection of adenovirus by layer hybridization method 20 (Table 1)
Testin yksityiskohdat selviävät taulukkotekstistä. Kerros-hybridisaatiomenetelmä kykenee osoittamaan virus-DNA:n liuoksesta, mutta yhtälailla virusgenomi on mahdollista 25 detektoida infektoiduista soluista.Details of the test can be found in the table text. The layer hybridization method is able to detect viral DNA from solution, but it is equally possible to detect the viral genome from infected cells.
Hybridisaation tausta mitataan putkessa, johon ei ole lisätty laisinkaan näytettä vaan ainoastaan filtteri ja leimattu nukleiinihapporeagenssi. Tausta johtuu leimatun nukleiini-30 happoreagenssin sisältämistä pBR322-jaksoista, jotka suoraan hybridisoituvat filtteriin ilman välittävää näytettä. Testissä kontrolleina käytetyt calf thymus ja tyhjät filtterit kuvaavat toisaalta hybridisaation spesifiteettiä ja toisaalta esim. pesujen riittämättömyydestä johtuvaa 35 epäspesifisen taustan suuruutta.The background of the hybridization is measured in a tube to which no sample has been added but only the filter and the labeled nucleic acid reagent. The background is due to the pBR322 sequences contained in the labeled nucleic acid acid reagent, which hybridize directly to the filter without a mediating sample. The calf thymus and empty filters used as controls in the test describe, on the one hand, the specificity of the hybridization and, on the other hand, the magnitude of the non-specific background due to, for example, insufficient washing.
Seuraavissa taulukoissa filttereille hybridisoituneista cpm-arvoista on vähennetty reagensseista johtuva tausta.In the following tables, the background due to reagents has been subtracted from the cpm values hybridized to the filters.
Taulukko 1 13 63596Table 1 13 63596
Adenovirustesti 5 Näyte Filtterit (cpm)Adenovirus Test 5 Sample Filters (cpm)
Adeno 1) Calf thymus 2) Blanko 3)Adeno 1) Calf thymus 2) Blanko 3)
Adenovirus 2-DNA (BRL) 10 (500 ng) 9000 49Adenovirus 2-DNA (BRL) 10 (500 ng) 9000 49
Adenoviruksella infektoidut HeLa-solut (6 x 10^) 8200 15Adenovirus-infected HeLa cells (6 x 10 ^) 8200 15
Filtterit; 13 Ad2D-pBR322-plasmidi 2 yug 2) Calf thymus DNA 1 yug (Boehringer Mannheim) 3) Blanko Cei DNA:ta) 20The filters; 13 Ad2D-pBR322 plasmid 2 yug 2) Calf thymus DNA 1 yug (Boehringer Mannheim) 3) Blanko Cei DNA) 20
Leimattu nukleiinihapporeagenssi;Labeled nucleic acid reagent;
Ad2_BamHI C-fragmentti puhdistettuna, spesifinen aktiviteetti 90 x 10^ cpm/^ig (200000 cpm ^"’i/reakt io) 25 Hybridisaatio:Ad2_BamHI C fragment purified, specific activity 90 x 10 ^ cpm / μg (200000 cpm ^ "'i / reaction) Hybridization:
50 % formamidi, 4 x SSC50% formamide, 4 x SSC
Denhardtin liuos, jossa 0,5 mg/ml salmon sperm DNA ja 1 % SDS, + 37°C, 16 t 30 Pesu; 0,1 x SSC, huoneenlämmössä 40 min Näytteet;Denhardt's solution with 0.5 mg / ml salmon sperm DNA and 1% SDS, + 37 ° C, 16 h 30 Wash; 0.1 x SSC, at room temperature 40 min Samples;
Adenovirus 2-DNA (BRL) 35 Adenovirus, tyyppiä 2 -infektio tapahtuu HeLa-soluissa. Solut hajoitetaan 1 % SDS-käsittelyllä, jonka jälkeen niille lisätään proteinaasi-K-entsyymi (Sigma) 1 mg/ml ja annetaan vaikuttaa +37°C:ssa 30 min. Ennen denatu-raatiota näyte puristetaan ohuen neulan läpi.Adenovirus 2-DNA (BRL) 35 Adenovirus, type 2 infection occurs in HeLa cells. The cells are lysed by 1% SDS treatment, followed by the addition of proteinase K enzyme (Sigma) 1 mg / ml and allowed to act at + 37 ° C for 30 min. Prior to denaturation, the sample is squeezed through a thin needle.
14 6359614 63596
Taulukon arvoista on vähennetty reagenssien aiheuttama tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in the table, the background caused by the reagents obtained from the corresponding hybridization without sample has been subtracted.
5 Esimerkki 2 RNA-yiruksen detektio kerroshybridisaatiomenetelmän avulla (taulukko 2) 10 RNA-virusmalIina käytetään Semliki Forest virusta (proto-tyyppikanta, saatu London School of Hygiene and Tropical Medicine'Itä), jonka genomi on yksisäikeistä RNArta.5 Example 2 Detection of RNA virus by the layer hybridization method (Table 2) 10 The RNA virus model used is Semliki Forest virus (prototype strain obtained from the London School of Hygiene and Tropical Medicine) whose genome is single-stranded RNA.
Virusgenomia mallina käyttäen valmistetaan cDNA, joka kloonataan pBR322-plasmidiin sen Pstl-katkaisukohtaan kuten 15 Garoff et ai. ovat kuvanneet (Proc. Natl. Acad. Sei. (1980) USA 77 6376 - 6380). Saatu rekombinanttiplasmidi on pKTH312 KTL n:o EH 232. Sen virusgenomista peräisin oleva osa on noin 1400 nukleotidia pitkä ja peräisin viruksen rakenneproteiinien alueelta, noin nukleotidista 200 20 nukleotidiin 1600, kun numerointi aloitetaan rakennegeeni-en alusta (Garoff, H. et ai. 1980). Reagenssivalmistusta varten koko rekombinanttiplasmidi pKTH312 linearisoidaan EcoRI-restriktioentsyymi1lä (BRL) (Semliki Forest viruksesta peräisin olevissa sekvensseissä ei ole EcoRI-entsyymin 25 tunnistuskohtaa), ja tämä puolestaan katkaistaan kahdeksi fragmentiksi XhoI-entsyymillä (BRL), jonka katkaisukohta paikantuu Semliki Forest viruksen sekvenssien alueelle. Suurempi EcoRI - XhoI-fragmentti A (noin 3900 emäsparia pitkä) kiinnitetään filtterille, kun pienempi fragmentti 125 30 B (noin 1850 emäsparia pitkä) leimataan I:lla nick translaation avulla.Using the viral genome as a template, cDNA is prepared and cloned into plasmid pBR322 at its PstI cleavage site as described by Garoff et al. have described (Proc. Natl. Acad. Sci. (1980) USA 77 6376-63880). The resulting recombinant plasmid is pKTH312 KTL No. EH 232. Its viral genome-derived portion is about 1400 nucleotides in length and originates in the region of viral structural proteins, from about nucleotide 200 to nucleotide 1600 when numbering begins at the beginning of structural genes (Garoff, H. et al. 1980 ). For reagent preparation, the entire recombinant plasmid pKTH312 is linearized with EcoRI restriction enzyme (BRL) (sequences derived from Semliki Forest virus do not have 25 EcoRI recognition sites), which in turn is cleaved into two fragments by the XhoI site (BRL). The larger EcoRI-XhoI fragment A (about 3900 bp in length) is attached to the filter when the smaller fragment 125 B (about 1850 bp in length) is labeled with I by nick translation.
Näytteenä kokeessa käytetään sekä kokonaista Semliki Forest virusta että Semliki Forest viruksella infektoituja soluja. 35 Molemmissa tapauksissa näytteen virusspesifiset nukleiinihapot koostuvat yksinomaan RNArsta.Both whole Semliki Forest virus and Semliki Forest virus-infected cells are used as samples in the experiment. 35 In both cases, the virus-specific nucleic acids in the sample consist exclusively of RNA.
Taulukko 2 15 63596Table 2 15 63596
Semliki Forest viruksen detektio kerroshybridisaatiomenetel-män avulla 5 __ Näyte Filtterit (cpm)Detection of Semliki Forest virus by layer hybridization 5__ Sample Filters (cpm)
Semliki Forest Calf thymus 2) Blanko 3) virus 1) 10 Semliki Forest virus 30 ^ig 3340 - 33Semliki Forest Calf thymus 2) Blanko 3) virus 1) 10 Semliki Forest virus 30 ^ to 3340 - 33
Semliki Forest viruksella infektoidut solut (5 x 105) 2698 8 10 15Semliki Forest virus infected cells (5 x 105) 2698 8 10 15
Ei infektoidut solut 10 5 8Uninfected cells 10 5 8
Filtterit; 20 1) pKTH312 plasmidin EcoRI-XhoI-fragmentti A 1,2 jug 2) Calf thymus DNA 1 /jg 3) Blanko (ei DNA:ta)The filters; 1) EcoRI-XhoI fragment A of plasmid pKTH312 A 1.2 [mu] g 2) Calf thymus DNA 1 / [mu] g 3) Blank (no DNA)
Leimatut nukleiinihapporeagenssit: 25 Plasmidin pKTH312 EcoRI-XhoI-fragmentti B, spesifinen c λ y c aktiviteetti 90 x 10 cpm//ug DNA (200000 cpm I/reaktio)Labeled nucleic acid reagents: EcoRI-XhoI fragment B of plasmid pKTH312, specific c λ y c activity 90 x 10 cpm // ug DNA (200,000 cpm I / reaction)
Hybridisaatio:hybridization:
Kuten esimerkissä 1 30As in Example 1 30
Pesu;Washing;
Kuten esimerkissä 1 Näytteet; 35 Semliki Forest virus 30 /jg hajoitetaan. SDS:llä ennen testiä. Infektoidut solut käsitellään kuten esimerkissä 1 on selostettu. Semliki Forest virusinfektio suoritetaan BHK-21-soluissa.As in Example 1 Samples; 35 Semliki Forest virus 30 μg is digested. With SDS before the test. Infected cells are treated as described in Example 1. Semliki Forest virus infection is performed in BHK-21 cells.
i ' l 16 63596i 'l 16 63596
Taulukon 2 arvoista on vähennetty reagenssien aiheuttama tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 2, the reagent-induced background obtained from the corresponding hybridization without sample has been subtracted.
5 Esimerkki 35 Example 3
Virusnäyte, jossa viruksen lähetti-RNA detektoidaan kerros hybridisaati omenetelmän avulla (taulukko 3) 10 Kerroshybridisaatioreagenssit valmistetaan SV40-viruksen DIMA:sta (BRL) siten, että DNA katkaistaan kahteen palaanVirus sample in which viral messenger RNA is detected by the layer hybridization method (Table 3) 10 Layer hybridization reagents are prepared from SV40 virus DIMA (BRL) by cutting the DNA into two pieces.
Pstl-entsyymin (Baehringer Mannheim) avulla (Lebowitz, P.Using the PstI enzyme (Baehringer Mannheim) (Lebowitz, P.
and Weissman, S.M. (1979) Curr. Topics in Microbiol.and Weissman, S.M. (1979) Curr. Topics in Microbiol.
Immunol, 8_7, 43 - 172) ja fragmentit eristetään ja puhdiste-Immunol, 8-7, 43-172) and fragments are isolated and purified
15 taan agaroosigeelielektroforeesin avulla. Fragmentti A15 by agarose gel electrophoresis. Fragment A
(4000 emäsparia) leimataan radioaktiiviseksi nick-trans-125 laatiossa I:llä ja fragmentti B (1220 emäsparia) kiinnitetään filtterille.(4000 bp) is radiolabeled in nick-trans-125 with I and fragment B (1220 bp) is attached to a filter.
20 ONA-fragmentit on valittu siten, että molemmissa on sekä myöhäisiä että aikaisia lähettejä koodittavia alueita. Niinpä B sisältää noin 700 emästä rakenneproteiini VP1:n geenistä ja yli 600 emästä aikaisten lähettien geenistä. Koska SV40-viruksen DNA sinänsä on kovalentisti suljettu 25 rengas, se ei sovellu testissä näytteeksi ilman, että se avataan lineaariseksi. Niinpä käytettäessä infektoituja soluja näytteenä voidaan testata, kuinka hyvin menetelmä soveltuu virusgenomin mukaan tehtyjen RNA-kopioiden osoittamiseen. Taulukosta 3 ilmenee, että testi soveltuu 30 erinomaisesti infektoitujen solujen tutkimiseen. Se demonstroi myös, että samoilla reagenssei1la voidaan tutkia sekä itse virus-DNA että sen mukaan tehdyt lähetti-RNAst.The ONA fragments are selected so that both have regions encoding both late and early transmissions. Thus, B contains about 700 bases of the structural protein VP1 gene and more than 600 bases of the early messenger gene. Because SV40 virus DNA itself is a covalently closed 25 ring, it is not suitable as a sample in the assay without being opened linearly. Thus, by using infected cells as a sample, it can be tested how well the method is suitable for detecting RNA copies made according to the viral genome. Table 3 shows that the test is suitable for examining 30 excellently infected cells. It also demonstrates that the same reagents can be used to examine both the viral DNA itself and the resulting messenger RNAs.
6359663596
Taulukko 3 1 7 SV40-virusten detektio kerroshybri-'disaatiomenetR·] mäi ι·ή 5 Näyte Filtterit (cpm) SV40 1) Calf thymus 2) Blanko 3)Table 3 1 7 Detection of SV40 viruses by layer hybridization procedures · sample 5 Filters (cpm) SV40 1) Calf thymus 2) Blanko 3)
Koe 1 SV4Q-virus-DNA (50 ng) 10 (linearisoitu) 20061 159 104Experiment 1 SV4Q virus DNA (50 ng) 10 (linearized) 20061 159 104
Ei näytettä - 1 5 Koe 2 SV40-viruksella infektoidut CV1-solut 40 t infektion jälkeen (10^ solua) 30814 294 530 20 Ei infektoidut solut -No sample - 1 5 Experiment 2 CV1 cells infected with SV40 virus 40 h after infection (10 ^ cells) 30814 294 530 20 Uninfected cells -
Filtterit: 1) SV40-viruksen sirkulaarisesta DNA:sta Pstl-restriktio- 25 entsyymillä katkaistu lyhyempi fragmentti PstI B 0,2 yug 2) Calf thymus DNA 1 /Jg 3) Blanko (ei DNA:ta)Filters: 1) Shorter fragment of SV40 virus circular DNA cleaved by PstI restriction enzyme PstI B 0.2 yug 2) Calf thymus DNA 1 / Jg 3) Blanko (no DNA)
Leimattu nukleiinihapporeagenssi: 30 sV40-viruksen-DNA:sta peräisin oleva pitempi PstI A-fragmentti, spesifinen aktiviteetti 28 x 106 cpm//Jg DNA (200000 cpm 125I/reaktio)Labeled Nucleic Acid Reagent: Longer PstI A fragment from 30 sV40 viral DNA, specific activity 28 x 106 cpm // Jg DNA (200,000 cpm 125I / reaction)
Hybridisaatio:hybridization:
Kuten esimerkissä 1 35 Hybridisaatioaika on 40 tuntiaAs in Example 1, the hybridization time is 40 hours
Pesu;Washing;
Kuten esimerkissä 1 18 63596 Näytteet: SV40-virus-DNA (BRL) on linearisoitu EcoRI- restriktioentsyymin (BRL) avulla. CV1-solut (Biomedical Centre, Upsala University) infektoidaan SV40-viruksella (saatu Janice Y.As in Example 1 18 63596 Samples: SV40 viral DNA (BRL) is linearized with EcoRI restriction enzyme (BRL). CV1 cells (Biomedical Center, Uppsala University) are infected with SV40 virus (obtained from Janice Y.
5 Chou & Robert G. Martinilta, NIH, Bethesda) ja solut kerätään 48 tuntia infektion jälkeen. Näytekäsittely tapahtuu kuten esimerkissä 1.5 from Chou & Robert G. Martin, NIH, Bethesda) and cells are harvested 48 hours after infection. Sample processing is performed as in Example 1.
Taulukon 3 arvoista on vähennetty reagenssien aiheuttama 10 tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 3, the background caused by the reagents obtained from the corresponding hybridization without sample has been subtracted.
Esimerkki 4 15 Bacillus amyloliquefaciensin detektio kerroshybridisaatio-menetelmän avulla (Taulukko 4)Example 4 Detection of Bacillus amyloliquefaciens by the layer hybridization method (Table 4)
Reagensseina on käytetty B. amyloliquefacjens* in E18 (VTT eli Valtion Teknillinen Tutkimuslaitos) o(-amylaasigeenin 20 fragmentteja, jotka on tätä testiä varten eristetty rekombi-nanttiplasmidi pKTH10:stä (Palva, I. et ai, (19Θ1) Gene, V5 43.-5 T) restri ktioentsyymikäsittelyn jälkeen agaroosigeeli-elektoroforeesin avulla. Testiä varten käytetyt fragmentit ovat 0(-amy laasigeenialueen Cla!>EcoRI-f ragmentti , (460 25 emäsparia) (Clal Boehringer Mannheim) ja EcoRI-BamHI-frag~ mentti (1500 emäsparia). Näistä EcoRI-BamHI-fragmentti kiinnitetään filtterille ja Clal-EcoRI-fragmentti leima*· taan l*L-li-isotaopi 1 la radioaktiiviseksi nick-translaation avu 1la.As reagents, fragments of the o (-amylase gene) of B. amyloliquefacjens * in E18 (VTT or State Technical Research Institute) isolated from the recombinant plasmid pKTH10 for this test have been used (Palva, I. et al., (19Θ1) Gene, V5 43 .-5 T) after restriction enzyme treatment by agarose gel electrophoresis The fragments used for the assay are the 0 (-amylase gene region ClaI> EcoRI fragment, (460 25 bp) (Clal Boehringer Mannheim) and the EcoRI-BamHI fragment ( Of these, the EcoRI-BamHI fragment is attached to a filter and the ClaI-EcoRI fragment is labeled with 1 * L-li isotope 11a radioactively by nick translation.
3030
Taulukosta 4 käy ilmi, että kerroshybridisaatiotekniikan avulla B. amyloliquefaciens on tunnistettavissa näytteestä sen sisältämän yhden (X-amylaasigeenin perusteella. E. coli oli testissä negatiivinen (antoi taustaan rinnastettavan 35 tuloksen).Table 4 shows that by the layer hybridization technique, B. amyloliquefaciens can be identified in the sample by one (based on the X-amylase gene. E. coli was negative in the test (gave a result comparable to 35 in the background).
19 6359619 63596
Taulukko 4Table 4
Bakteeridiagnostiikka kerroshybridisaation avulla 5 Näyte Filtterit (cpm) 0(-amylaasi 1] Calf thymus 2) Blanko 3)Bacterial diagnostics by layer hybridization 5 Sample Filters (cpm) 0 (-amylase 1] Calf thymus 2) Blanko 3)
pKTHlQ-plasmidi-DNApKTHlQ plasmid DNA
(linearisoitu) 1 μg 5773 47 10(linearized) 1 μg 5773 47 10
Ei näytettä - E. coli HB101 (109) - - 1 5 Bacillus amylolique- faciens (3 x 10 ) 3377No sample - E. coli HB101 (109) - - 1 5 Bacillus amylolique- faciens (3 x 10) 3377
Bacillus amylolique- faciens (109) 2871 20 _I___Bacillus amylolique- faciens (109) 2871 20 _I___
Filtterit; 1) pKTH10-plasmidin (X-amylaasigeenin EcoRI-BamHI-fragmentti 0,35 yug 25 2) Calf thymus DNA 1 ^ug 31 Blanko (ei DNA:ta)The filters; 1) Plasmid pKTH10 (EcoRI-BamHI fragment of the X-amylase gene 0.35 μg 25 2) Calf thymus DNA 1 μg 31 Blanko (no DNA)
Leimattu nukleiinihapporeagenssi: pKTHIO-plasmidin CV-amy laasigeenin Clal-EcoRI-f ragmentti , 6 125 30 spesifinen aktiivisuus 35 x 10 cprrv^ug (200000 cpm I/reaktio)Labeled nucleic acid reagent: ClaI-EcoRI fragment of the CV-Amy lasal gene of the pKTHIO plasmid, 6 125 30 specific activity 35 x 10 cprrv ug (200,000 cpm I / reaction)
Hybridisaatio:hybridization:
Kuten esimerkissä 1 35 Pesu:As in Example 1 35 Washing:
Kuten esimerkissä 1 20 63596 Näytteet:As in Example 1 20 63596 Samples:
Bakteerinäytteet käsitellään lysotsyyrai 1 lä (67 yug/ml) 30 min +37°C; E. coli näytteeseen lisätään myös 5 mM EDTA. Käsittelyn loputtua kaikille näytteille lisätään SDS (2 %), 5 näytteet puristetaan ohuen neulan läpi kaksi kertaa viskositeetin alentamiseksi ja denaturoidaan keittämällä, kuten on kuvattu tekstissä näytekäsittelyn yhteydessä.Bacterial samples are treated with lysocyr (1 μg / ml) for 30 min at + 37 ° C; 5 mM EDTA is also added to the E. coli sample. At the end of the treatment, SDS (2%) is added to all samples, the samples are pressed through a thin needle twice to reduce the viscosity and denatured by boiling as described in the text during sample processing.
Taulukon 4 arvoista on vähennetty reagenssien aiheuttama 10 tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 4, the background caused by the reagents 10 obtained from the corresponding hybridization without sample has been subtracted.
Esimerkki 5 15 Esimerkki kerroshybridisaatiomenetelmään perustuvasta "kittinä” toimivasta reagenssien yhdistelmästä (taulukko 5) Näytteinä tällä testillä tutkitaan kolmella eri viruksella infektoituja soluja (adenovirus, SV40 virus ja Herpes 20 simplex virus) sekä Bacillus amyloliquefaciens-bakteeria sisältävä näyte. Kuhunkin näytteeseen sekoitetaan yhtäaikaisesti kaikki seuraavat reagenssit: filttereistä 1 kpl SV40-virus, adenovirus-, Bacillus amyloliquefaciensin Λ-amylaasigeeni- ja calf thymus-DNA:ta sisältävä filtteri 25 sekä yksi tyhjä filtteri; näiden lisäksi 200000 cpm kutakin seuraavista leimatuista nukleiinihapporeagensseista: SV40-virus-, adenovirus- ja 0(-amylaasigeeni-DNA-reagenssit,Example 5 Example of a combination of reagents acting as a "putty" based on the layer hybridization method (Table 5) As samples in this test, cells infected with three different viruses (adenovirus, SV40 virus and Herpes 20 simplex virus) and Bacillus amyloliquefaciens are all sampled into each sample. reagents: 1 filter containing SV40 virus, a filter containing 25 adenovirus, Bacillus amyloliquefaciens am-amylase gene and calf thymus DNA and one empty filter, in addition to 200000 cpm of each of the following labeled nucleic acid reagents: SV40 virus and adenovirus 0 (-amylaasigeeni DNA reagents,
Esimerkkimme osoittaa, että näytteestä voidaan sitä laimen-30 tamatta ja jakamatta tutkia samalla kertaa tarkoituksenmukainen sarja mikrobeja sekoittamalla reagenssit näytteeseen. Näytteenä voi toimia sekä virus- että bakteerinukleiinihappo. Näytteessä olevan mikrobin identifiointi on helppoa, koska se tapahtuu tunnuksilla 35 varustettujen filttereiden perusteella.Our example shows that an appropriate set of microbes can be tested on a sample at the same time without diluting and dividing it by mixing the reagents in the sample. Both viral and bacterial nucleic acid can serve as samples. The identification of the microbe in the sample is easy because it is done on the basis of filters marked 35.
Taulukko 5 21 63596Table 5 21 63596
Kerroshybridisaatiomenetelmään perustuva kit 5 Näyte Filtterit (cpm) SV40 1) Adeno 2) 0(-arry- Calf Blanko 5) laasi 3) thymus 4) SV40-viruksella irifek- 10 toidut solut MO6) 16390 2 13 22 31Kit based on the layer hybridization method 5 Sample Filters (cpm) SV40 1) Adeno 2) 0 (-arry- Calf Blanko 5) glass 3) thymus 4) SV40 virus irifinfected cells MO6) 16390 2 13 22 31
Adeno-2-viruksella infektoidut solut (6 x 105) - 6750 5 13 15Cells infected with Adeno-2 virus (6 x 105) - 6750 5 13 15
Herpes simplex-viruk-sella infektoidut solut MO6) - 5 13 20 Bacillus amylolique- faciens MQ9) 15 8 6500 16 5Cells infected with the herpes simplex virus MO6) - 5 13 20 Bacillus amylolique- faciens MQ9) 15 8 6500 16 5
Ei infektoidut solut 25Uninfected cells 25
Filtterit; 1) kuten esimerkissä 3 2) kuten esimerkissä 1 3) kuten esimerkissä 4 30 4) Calf thymus DNA 1 yug 5) Blanko (ei DNA:ta)The filters; 1) as in Example 3 2) as in Example 1 3) as in Example 4 30 4) Calf thymus DNA 1 yug 5) Blanko (no DNA)
Leimatut nukleiinihapporeagenssit: SV40“virus kuten esimerkissä 3 35 Adenovirus kuten esimerkissä 1 (X-amy laasi geeni kuten esimerkissä 4 22Labeled nucleic acid reagents: SV40 virus as in Example 3 35 Adenovirus as in Example 1 (X-Amy glass gene as in Example 4 22
Hybridisaatio; 63596hybridization; 63596
Kuten esimerkissä 1 Pesu: 5 Kuten esimerkissä 1 Näytteet: SV40 viruksella infektoidut solunäytteet on selostettu taulukossa 3. Adenoviruksella infektoidut solunäytteet 10 on selostettu taulukossa 1.As in Example 1 Washing: 5 As in Example 1 Samples: SV40 virus infected cell samples are described in Table 3. Adenovirus infected cell samples 10 are described in Table 1.
00
Herpes simplex, tyyppiä 1 viruksella infektoidaan 10 Vero-solua. Solut kerätään näytteeksi 20 tunnin kasvatuksen jälkeen, kun soluissa voidaan mikroskooppisesti havaita 15 virusinfektion merkit. Näyte käsitellään samoin kuin adenoviruksella infektoidut solut (esimerkki 1).Herpes simplex, a type 1 virus, infects 10 Vero cells. Cells are harvested after 20 hours of culture, when microscopic signs of viral infection can be detected in the cells. The sample is treated in the same way as adenovirus-infected cells (Example 1).
Bacillus amyloliquefaciens näyte:Sample of Bacillus amyloliquefaciens:
Kuten taulukossa 4 20As in Table 4 20
Taulukon 5 arvoista on vähennetty reagenssien aiheuttama tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 5, the reagent-induced background obtained from the corresponding hybridization without sample has been subtracted.
Il 63596 23 5Il 63596 23 5
Esimerkki 6Example 6
Escherichia colin detektio kerroshybridisaatiomenetelmän avu 11a (Taulukko 6)Detection of Escherichia coli by the layer hybridization method 11a (Table 6)
Testireagenssit valmistettiin E. colin ompA-geenin fragmenteista. OmpA (outer memhrane protein A) on E. colin ulko-membraaniprotei i ni.Test reagents were prepared from fragments of the E. coli ompA gene. OmpA (outer memhrane protein A) is an outer membrane protein of E. coli.
10 Lähtömateriaalina käytettiin SITRA:n yhdistelmä-DNA-ryhmän (Pauli Kallio, pro gradu-tutkielma, Helsingin yliopiston yleisen mikrobiologian laitos) pTU100 plasmidista (Henning et ai. ( 1979), proc. Natl. Acad. Sei. U.S.A. 7_6, 4360-4364) prosessoimia hybridiplasmideja pKTH40 ja pKTH45.10 The plasmid pTU100 from the SITRA recombinant DNA group (Pauli Kallio, master's thesis, Department of General Microbiology, University of Helsinki) (Henning et al. (1979), Proc. Natl. Acad. Sci. USA 7_6, 4360-) was used as starting material. 4364) processed hybrid plasmids pKTH40 and pKTH45.
15 pKTH45-plasmidia (deponoitu KTLrlle no:lla EH254), joka sisältää 740 emäsparia ompA-geenin 5’ -päästä pBR322-plasmidiin liitettynä, käytettiin suoraan filtterireagens-s ina.Plasmid pKTH45 (deposited with KTL No. EH254) containing 740 base pairs from the 5 'end of the ompA gene fused to plasmid pBR322 was used directly as a filter reagent.
20 pKTH40-plasmidi sisältää noin 300 emäsparia ompA-geenin 3' -päästä ja sitä välittömästi seuraavat noin 1400 emäs-paria E. colin muuta genomia. pKTH40 pilkottiin BamHI restriktioentsyymillä, jolloin saatiin yhteensä 1700 25 emäsparia käsittävä E. colista peräisin oleva DNA-frag* mentti. Se siirrettiin yksisäikeiseen bakteriofaagiin M13mp7 (Messing et ai. (19B1), Nucl. Acids Res. £, 309-321, Heidecker et ai. (19Θ0), Gene _1_0, 69-73, Gardner et ai. (19Θ1), Nucl. Acids Res. £, 2871-286Θ). Saatua yhdistel-30 mäfaagia, mKTH12Q7 (deponoitu KTL:lle noilla EH256), käytettiin kerroshybridisaatiossa koettimena leimaamalla 12 5 se J-isotoopilla radioaktiiviseksi kuten on kuvattu kohdassa "Muu leimaus" sivu 9.Plasmid pKTH40 contains about 300 base pairs from the 3 'end of the ompA gene, immediately followed by about 1400 base pairs from the rest of the E. coli genome. pKTH40 was digested with the restriction enzyme BamHI to give a DNA fragment from E. coli of a total of 1700 25 base pairs. It was transferred to single-stranded bacteriophage M13mp7 (Messing et al. (19B1), Nucl. Acids Res. E, 309-321, Heidecker et al. Acids Res., 2871-286Θ). The resulting recombinant mage phage, mKTH12Q7 (deposited on the KTL with those EH256), was used in layer hybridization as a probe by labeling it with a J-isotope radioactive as described in "Other Labeling" on page 9.
35 Kuten testistä (taulukko 6) ilmenee, voidaan sekä rikot- tujen E. coli solujen DNA että E. colista eristetty puhdas DNA detektoida kerroshybridisaatiomenetelmän avulla.As shown in the assay (Table 6), both DNA from disrupted E. coli cells and pure DNA isolated from E. coli can be detected by a layer hybridization method.
Taulukko 6 24 63596Table 6 24 63596
Escherichia coli-bakteerin detektio kerroshybridisaatio’· menetelmän avulla 5 __ Näyte Filtterit (cpm) ompA 1) Calf thymus 2) Sianko 3) E. coli K12 HB101'DNA 10 a) 2 x 107 282Detection of Escherichia coli by the layer hybridisation method · __ Sample Filters (cpm) ompA 1) Calf thymus 2) Pig 3) E. coli K12 HB101'DNA 10 a) 2 x 107 282
E. coli K12 HB101 DNAE. coli K12 HB101 DNA
a) 2 x 108 2206 15 E. coli K12 HB101 solut b) 2 x 107 1113 E. coli K.12 HB101 solut b) 2 x 10® 2327 12 5 20 _____ a) DNA-molekyylien lukumäärä, b) solujen lukumääräa) 2 x 108 2206 15 E. coli K12 HB101 cells b) 2 x 107 1113 E. coli K.12 HB101 cells b) 2 x 10® 2327 12 5 20 _____ a) Number of DNA molecules, b) Number of cells
Filtterit: 25 1) pKTH45 plasmidi 1,088 jug (2 x 10^ molekyyliä) 2) Calf thymus DNA 1,088 ;ug 3) Blanko (ei DNA:ta)Filters: 25 1) pKTH45 plasmid 1.088 μg (2 x 10 ^ molecules) 2) Calf thymus DNA 1.088; ug 3) Blanko (no DNA)
Leimatut nukleiinihapporeagenssit; 30 mKTH 1207, spesifinen aktiviteetti 8 x 107 cpm/jug DNA (200000 cpm/reaktio)Labeled nucleic acid reagents; 30 mKTH 1207, specific activity 8 x 107 cpm / μg DNA (200,000 cpm / reaction)
Hybridisaatio; 4 x SSC, 1 x Denhardt ilman BSA:ta (bovin serum albumin),hybridization; 4 x SSC, 1 x Denhardt without BSA (bovin Serum album),
35 0,25 % SDS, 200 /ug/ml Herring sperm DNA, 17,5 h, ♦65°C0.25% SDS, 200 ug / ml Herring sperm DNA, 17.5 h, ♦ 65 ° C
Pesu;Washing;
Kuten esimerkissä 1 63596 25 Näytteet: E. coli K12 HB101 - DNA eristettiin Marmur-menetelmälla (Marmur (1961), J. Mol. Biol. 3, 208-21Θ). DNA:n denatu-raatio testiä varten tehtiin 7 mM NaGH, 100 C, 5 min.As in Example 1 63596 Samples: E. coli K12 HB101 DNA was isolated by the Marmur method (Marmur (1961), J. Mol. Biol. 3, 208-21Θ). DNA denaturation for the assay was performed with 7 mM NaGH, 100 ° C, 5 min.
5 Solut hajotettiin lysotsyymi (500 /jg/ml), EDTA (70 mM, + 37°C, 30 min), SOS (0,25 %, +65°C, 15 min) käsittelyllä ja vapautunut DNA denaturoitiin alkalikeitolla (14 mM NaOH, +100°C, 5 min).Cells were lysed by treatment with lysozyme (500 μg / ml), EDTA (70 mM, + 37 ° C, 30 min), SOS (0.25%, + 65 ° C, 15 min) and the released DNA was denatured with alkaline soup (14 mM NaOH, + 100 ° C, 5 min).
10 Taulukon 6 arvoista on vähennetty reagenssien aiheuttama tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 6, the background caused by the reagents obtained from the corresponding hybridization without sample has been subtracted.
Claims (10)
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI813251A FI63596C (en) | 1981-10-16 | 1981-10-16 | MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER |
| PCT/FI1982/000038 WO1983001459A1 (en) | 1981-10-16 | 1982-09-29 | A method and reagent combination for the diagnosis of microorganisms by sandwich hybridization of nucleic acids |
| EP82902982A EP0098267A1 (en) | 1981-10-16 | 1982-09-29 | A method and reagent combination for the diagnosis of microorganisms by sandwich hybridization of nucleic acids |
| AU89575/82A AU548854B2 (en) | 1981-10-16 | 1982-09-29 | A method and reagent combination for the diagnosis of microorganisms |
| JP57502956A JPS58501703A (en) | 1981-10-16 | 1982-09-29 | Combination of microbial identification methods and microbial identification reagents |
| HU823529A HU196242B (en) | 1981-10-16 | 1982-09-29 | Process and reagent combination for identifying microorganisms by sandwich-hybridization of nucleic acids |
| JP57-502956A JPH0632637B2 (en) | 1981-10-16 | 1982-09-29 | Combination of microbial identification method and microbial identification reagent |
| FI823452A FI823452A0 (en) | 1981-10-16 | 1982-10-11 | FOERFARANDE FOER STABILIZERING AV I NUCLEINSYREHYBRIDISERING ANVAENDA FILTER |
| US06/434,182 US4486539A (en) | 1981-10-16 | 1982-10-14 | Detection of microbial nucleic acids by a one-step sandwich hybridization test |
| DE8282305489T DE3277917D1 (en) | 1981-10-16 | 1982-10-15 | A method and reagent combination for the identification of microorganisms and the use of sandwich hybridization of nucleic acids therefor |
| DE198282305489T DE79139T1 (en) | 1981-10-16 | 1982-10-15 | METHOD AND REAGENT COMBINATION FOR THE IDENTIFICATION OF MICROORGANISMS AND THE APPLICATION OF SANDWICH HYBRIDIZATION OF NUCLEIC ACIDS FOR THIS. |
| EP82305489A EP0079139B1 (en) | 1981-10-16 | 1982-10-15 | A method and reagent combination for the identification of microorganisms and the use of sandwich hybridization of nucleic acids therefor |
| AT82305489T ATE31735T1 (en) | 1981-10-16 | 1982-10-15 | METHOD AND REAGENT COMBINATION FOR THE IDENTIFICATION OF MICROORGANISMS AND THE APPLICATION OF SANDWICH HYBRIDIZATION OF NUCLEIC ACIDS THEREFOR. |
| CA000413539A CA1192120A (en) | 1981-10-16 | 1982-10-15 | Method and reagent combination for the diagnosis of microorganisms |
| NO83832061A NO163699C (en) | 1981-10-16 | 1983-06-07 | PROCEDURE AND REAGENT COMBINATION FOR DIAGNOSIS OF MICROORGANISMS. |
| DK198302751A DK173744B1 (en) | 1981-10-16 | 1983-06-15 | Method and reagent combination for diagnosis of microorganisms |
| SU833663405A SU1386031A3 (en) | 1981-10-16 | 1983-11-15 | Method of identifying viruses and bacteria |
| RO112563A RO86356B (en) | 1981-10-16 | 1983-11-15 | Microbial identification method |
| US06/566,532 US4563419A (en) | 1981-10-16 | 1983-12-29 | Detection of microbial nucleic acids by a one-step sandwich hybridization test |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI813251 | 1981-10-16 | ||
| FI813251A FI63596C (en) | 1981-10-16 | 1981-10-16 | MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI63596B FI63596B (en) | 1983-03-31 |
| FI63596C true FI63596C (en) | 1983-07-11 |
Family
ID=8514776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI813251A FI63596C (en) | 1981-10-16 | 1981-10-16 | MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US4486539A (en) |
| EP (2) | EP0098267A1 (en) |
| JP (2) | JPH0632637B2 (en) |
| AT (1) | ATE31735T1 (en) |
| AU (1) | AU548854B2 (en) |
| CA (1) | CA1192120A (en) |
| DE (2) | DE3277917D1 (en) |
| DK (1) | DK173744B1 (en) |
| FI (1) | FI63596C (en) |
| HU (1) | HU196242B (en) |
| RO (1) | RO86356B (en) |
| SU (1) | SU1386031A3 (en) |
| WO (1) | WO1983001459A1 (en) |
Families Citing this family (342)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI63596C (en) * | 1981-10-16 | 1983-07-11 | Orion Yhtymae Oy | MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER |
| US5612183A (en) * | 1983-01-10 | 1997-03-18 | Gen-Probe Incorporated | Method for determining the effect of antimicrobial agents on growth using ribosomal nucleic acid subunit subsequence specific probes |
| US5723597A (en) * | 1983-01-10 | 1998-03-03 | Gen-Probe Incorporated | Ribosomal nucleic acid probes for detecting organisms or groups of organisms |
| US5288611A (en) * | 1983-01-10 | 1994-02-22 | Gen-Probe Incorporated | Method for detecting, identifying, and quantitating organisms and viruses |
| US4689295A (en) * | 1983-01-20 | 1987-08-25 | Integrated Genetics, Inc. | Test for Salmonella |
| US4994373A (en) | 1983-01-27 | 1991-02-19 | Enzo Biochem, Inc. | Method and structures employing chemically-labelled polynucleotide probes |
| US4948882A (en) * | 1983-02-22 | 1990-08-14 | Syngene, Inc. | Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis |
| WO1984003285A1 (en) * | 1983-02-22 | 1984-08-30 | Molecular Biosystems Inc | Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis |
| US5593832A (en) * | 1983-02-28 | 1997-01-14 | Lifecodes Corporation | Method for forensic analysis |
| IL71064A (en) * | 1983-02-28 | 1989-10-31 | Lifecodes Corp | Paternity and forensic test involving analysis of dna polymorphic genetic regions |
| CA1228811A (en) | 1983-05-05 | 1987-11-03 | Robert G. Pergolizzi | Assay method utilizing polynucleotide sequences |
| CA1222680A (en) * | 1983-07-05 | 1987-06-09 | Nanibhushan Dattagupta | Testing dna samples for particular nucleotide sequences |
| US4737454A (en) * | 1983-07-14 | 1988-04-12 | Molecular Diagnostics, Inc. | Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays |
| US4959309A (en) * | 1983-07-14 | 1990-09-25 | Molecular Diagnostics, Inc. | Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays |
| CA1231303A (en) * | 1983-08-05 | 1988-01-12 | Robert J. Carrico | Detection of bacteria by nucleic acid hybridization |
| US5539097A (en) * | 1983-09-02 | 1996-07-23 | Molecular Biosystems, Inc. | Oligonucleotide polymeric support system |
| JPS6091999A (en) * | 1983-10-25 | 1985-05-23 | Fujirebio Inc | Measurement of polynucleotide |
| GB8331071D0 (en) * | 1983-11-22 | 1983-12-29 | Karayiannis P | Assay for dna/rna |
| US4724202A (en) * | 1983-12-12 | 1988-02-09 | Molecular Diagnostics, Inc. | Use of non-hybridizable nucleic acids for the detection of nucleic acid hybridization |
| US4777129A (en) * | 1983-12-12 | 1988-10-11 | Molecular Diagnostics, Inc. | Nucleic acid probe detectable by specific nucleic acid binding protein |
| IL73577A (en) * | 1983-12-12 | 1989-10-31 | Miles Lab | Method and reagent system for detecting dna or rna sequences in a test medium containing single stranded dna or rna using antibodies to intercalation complexes with double stranded nucleic acid |
| US4849505A (en) * | 1984-01-30 | 1989-07-18 | Enzo Biochem, Inc. | Detectable molecules, method of preparation and use |
| US4943523A (en) * | 1984-01-30 | 1990-07-24 | Enzo Biochem, Inc. | Detectable molecules, method of preparation and use |
| US4849208A (en) * | 1984-01-30 | 1989-07-18 | Enzo Biochem, Inc. | Detectable molecules, method of preparation and use |
| US5002885A (en) * | 1984-01-30 | 1991-03-26 | Enzo Biochem, Inc. | Detectable molecules, method preparation and use |
| US4843122A (en) * | 1984-01-30 | 1989-06-27 | Enzo Biochem, Inc. | Detectable molecules, method of preparation and use |
| US4707440A (en) * | 1984-01-30 | 1987-11-17 | Enzo Biochem, Inc. | Nucleic acid hybridization assay and detectable molecules useful in such assay |
| FI71768C (en) * | 1984-02-17 | 1987-02-09 | Orion Yhtymae Oy | FOERBAETTRADE NYKLEINSYRAREAGENSER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. |
| CA1223222A (en) * | 1984-02-22 | 1987-06-23 | Nanibhushan Dattagupta | Immobilized nucleic acid-containing probes |
| JPH06100605B2 (en) * | 1984-04-05 | 1994-12-12 | ハワ−ド フロ−リ インステイチユ−ト オブ イクスペリメンタル フイジオロジ アンド メデイスン | Hybridization histochemistry |
| US6221581B1 (en) * | 1984-04-27 | 2001-04-24 | Enzo Diagnostics, Inc. | Processes for detecting polynucleotides, determining genetic mutations or defects in genetic material, separating or isolating nucleic acid of interest from samples, and useful compositions of matter and multihybrid complex compositions |
| US5288609A (en) * | 1984-04-27 | 1994-02-22 | Enzo Diagnostics, Inc. | Capture sandwich hybridization method and composition |
| CA1260372A (en) * | 1984-04-27 | 1989-09-26 | Elazar Rabbani | Hybridization method for the detection of genetic materials |
| US4766062A (en) * | 1984-05-07 | 1988-08-23 | Allied Corporation | Displacement polynucleotide assay method and polynucleotide complex reagent therefor |
| US4766064A (en) * | 1984-05-07 | 1988-08-23 | Allied Corporation | Displacement polynucleotide assay employing polyether and diagnostic kit |
| US4670380A (en) * | 1984-05-23 | 1987-06-02 | Molecular Diagnostics, Inc. | Assays utilizing labeled nucleic acid probes |
| US5132206A (en) * | 1984-06-11 | 1992-07-21 | Dreyer William J | Fluorescent pigments for tagging biological molecules |
| US4749647A (en) * | 1984-06-22 | 1988-06-07 | Genetic Systems Corporation | Polymerization-induced separation assay using recognition pairs |
| FR2567541B1 (en) * | 1984-07-13 | 1987-02-06 | Pasteur Institut | DNA PROBE AND METHOD FOR THE DETECTION OF "SHIGELLES" AND ENTERO-INVASIVE STRAINS OF ESCHERICHIA COLI |
| US4755458A (en) * | 1984-08-30 | 1988-07-05 | Enzo Biochem, Inc. | Composition and method for the detection of the presence of a polynucleotide sequence of interest |
| US4563417A (en) * | 1984-08-31 | 1986-01-07 | Miles Laboratories, Inc. | Nucleic acid hybridization assay employing antibodies to intercalation complexes |
| US5955261A (en) * | 1984-09-04 | 1999-09-21 | Gen-Probe Incorporated | Method for detecting the presence of group-specific viral mRNA in a sample |
| US5430136A (en) * | 1984-10-16 | 1995-07-04 | Chiron Corporation | Oligonucleotides having selectably cleavable and/or abasic sites |
| US4775619A (en) * | 1984-10-16 | 1988-10-04 | Chiron Corporation | Polynucleotide determination with selectable cleavage sites |
| US4820630A (en) * | 1984-11-23 | 1989-04-11 | Digene Diagnostics, Incorporated | Assay for nucleic acid sequences, particularly genetic lesions, using interactive labels |
| US4734363A (en) * | 1984-11-27 | 1988-03-29 | Molecular Diagnostics, Inc. | Large scale production of DNA probes |
| US5242794A (en) * | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US4883750A (en) * | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| GB8432118D0 (en) * | 1984-12-19 | 1985-01-30 | Malcolm A D B | Sandwich hybridisation technique |
| GB2179448B (en) * | 1984-12-19 | 1989-06-07 | Blair Malcolm A D | Improved sandwich hybridisation technique for the detection of nucleotide sequences |
| US4670379A (en) * | 1984-12-19 | 1987-06-02 | E. I. Du Pont De Nemours And Company | Polynucleotide hydridization assays employing catalyzed luminescence |
| FI72146C (en) * | 1985-01-02 | 1987-04-13 | Orion Yhtymae Oy | Procedure for Identifying Nucleic Acids. |
| US4785086A (en) * | 1985-01-17 | 1988-11-15 | Integrated Genetics, Inc. | Test for Campylobacter |
| US5851767A (en) * | 1985-03-04 | 1998-12-22 | The Regents Of The University Of California | Detection of prokaryotic organism by DNA hybridization |
| US4792519A (en) * | 1985-03-05 | 1988-12-20 | International Technology Corporation | Method for the monitoring and control of microbial populations |
| US5217866A (en) * | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
| US5470974A (en) * | 1985-03-15 | 1995-11-28 | Neu-Gene Development Group | Uncharged polynucleotide-binding polymers |
| US6040166A (en) * | 1985-03-28 | 2000-03-21 | Roche Molecular Systems, Inc. | Kits for amplifying and detecting nucleic acid sequences, including a probe |
| US6197563B1 (en) | 1985-03-28 | 2001-03-06 | Roche Molecular Systems, Inc. | Kits for amplifying and detecting nucleic acid sequences |
| EP0200113A3 (en) * | 1985-04-30 | 1987-03-18 | Pandex Laboratories, Inc. | A method of solid phase nucleic acid hybridization assay incorporating a luminescent label |
| US5273882A (en) * | 1985-06-13 | 1993-12-28 | Amgen | Method and kit for performing nucleic acid hybridization assays |
| US4751177A (en) * | 1985-06-13 | 1988-06-14 | Amgen | Methods and kits for performing nucleic acid hybridization assays |
| IL79112A (en) * | 1985-06-13 | 1992-01-15 | Abbott Lab | Method for the isolation of a nucleic acid sequence and kit for performing a hybridization assay |
| US5641630A (en) * | 1985-06-13 | 1997-06-24 | Amgen Inc. | Method and kit for performing nucleic acid hybridization assays |
| AU558846B2 (en) * | 1985-06-21 | 1987-02-12 | Miles Laboratories Inc. | Solid-phase hydridization assay using anti-hybrid antibodies |
| US4831125A (en) * | 1985-07-01 | 1989-05-16 | E. I. Du Pont De Nemours And Company | DNA probe for corynebacterium kutscheri |
| US4824776A (en) * | 1985-07-25 | 1989-04-25 | Molecular Biosystems, Inc. | Method for increasing the sensitivity of nucleic acid hybridization assays |
| US5155216A (en) * | 1985-08-15 | 1992-10-13 | Amoco Corporation | Nucleic acids labeled with a chemiluminescent acridine ester |
| US4868104A (en) * | 1985-09-06 | 1989-09-19 | Syntex (U.S.A.) Inc. | Homogeneous assay for specific polynucleotides |
| US5595908A (en) * | 1985-09-26 | 1997-01-21 | University Of Southern Mississipi | Piezoelectric device for detection of polynucleotide hybridization |
| EP0244471A4 (en) * | 1985-10-24 | 1988-01-28 | Siska Diagnostics Inc | Lanthanide chelate-tagged nucleic acid probes. |
| US5258283A (en) * | 1985-11-05 | 1993-11-02 | Battelle Memorial Institute | Detection and differentiation of coxiella burnetii in biological fluids |
| US4876186A (en) * | 1985-11-05 | 1989-10-24 | Battelle Development Corporation | Detection and differentiation of coxiella burnetii in biological fluids |
| JPS63502477A (en) * | 1985-12-03 | 1988-09-22 | エル・ギユ−リイ・エム・ラフアツト | Methods, devices and products for disease diagnosis |
| US4910300A (en) * | 1985-12-11 | 1990-03-20 | Chiron Corporation | Method for making nucleic acid probes |
| US4868105A (en) * | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
| US4882269A (en) * | 1985-12-13 | 1989-11-21 | Princeton University | Amplified hybridization assay |
| JP3293820B2 (en) * | 1985-12-13 | 2002-06-17 | エンゾ− バイオケム インコ−ポレイテツド | Novel one-step method and polynucleotide compound for hybridizing to target polynucleotide |
| FI76119C (en) * | 1986-02-27 | 1988-09-09 | Orion Yhtymae Oy | QUANTITATIVE BEARING OF NUCLEIN SYRAMOLEKYLER AND REAGENTS FOERPACKNING SOM ANVAENDS VID FOERFARANDET. |
| US4968602A (en) * | 1986-03-05 | 1990-11-06 | Molecular Diagnostics, Inc. | Solution-phase single hybridization assay for detecting polynucleotide sequences |
| US5242823A (en) * | 1986-03-07 | 1993-09-07 | International Genetic Engineering, Inc. | Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen |
| US4925785A (en) * | 1986-03-07 | 1990-05-15 | Biotechnica Diagnostics, Inc. | Nucleic acid hybridization assays |
| EP0250662B1 (en) * | 1986-06-25 | 1994-08-24 | The Regents Of The University Of California | Detection of mycoplasma by DNA hybridization |
| JP2534529B2 (en) * | 1986-07-24 | 1996-09-18 | ブリティシュ・テレコミュニケ−ションズ・パブリック・リミテッド・カンパニ | Radiation generator |
| EP0276302B1 (en) * | 1986-08-11 | 1993-04-28 | Siska Diagnostics,Inc. | Nucleic acid probe assay methods and compositions |
| US5849478A (en) * | 1986-08-14 | 1998-12-15 | Cashman; Daniel P. | Blocked-polymerase polynucleotide immunoassay method and kit |
| US4917999A (en) * | 1986-09-02 | 1990-04-17 | Miles Inc. | Oligonucleotide probes for detection of α-amylase genes |
| US5714380A (en) | 1986-10-23 | 1998-02-03 | Amoco Corporation | Closed vessel for isolating target molecules and for performing amplification |
| US7087742B1 (en) | 1986-11-24 | 2006-08-08 | Gen-Probe Incorporated | Oligonucleotide probes for the detection and/or quantitation of non-viral organisms |
| US5994059A (en) * | 1986-11-24 | 1999-11-30 | Gen-Probe Incorporated | Nucleic acid probes and methods for detecting Streptomyces enterococci |
| US6150517A (en) * | 1986-11-24 | 2000-11-21 | Gen-Probe | Methods for making oligonucleotide probes for the detection and/or quantitation of non-viral organisms |
| US7138516B1 (en) | 1986-11-24 | 2006-11-21 | Gen-Probe Incorporated | Oligonucleotide probes for the detection and/or quantitation of non-viral organisms |
| US5541308A (en) * | 1986-11-24 | 1996-07-30 | Gen-Probe Incorporated | Nucleic acid probes for detection and/or quantitation of non-viral organisms |
| US4994372A (en) * | 1987-01-14 | 1991-02-19 | President And Fellows Of Harvard College | DNA sequencing |
| US4795699A (en) * | 1987-01-14 | 1989-01-03 | President And Fellows Of Harvard College | T7 DNA polymerase |
| US5266466A (en) * | 1987-01-14 | 1993-11-30 | President And Fellows Of Harvard College | Method of using T7 DNA polymerase to label the 3' end of a DNA molecule |
| US5145776A (en) * | 1987-01-14 | 1992-09-08 | President & Fellows Of Harvard College | Method of using T7 DNA polymerase to mutagenize and fill-in DNA |
| US4942130A (en) * | 1987-01-14 | 1990-07-17 | President & Fellows Of Harvard College | T7 DNA polymerase |
| US4946786A (en) * | 1987-01-14 | 1990-08-07 | President And Fellows Of Harvard College | T7 DNA polymerase |
| US5599667A (en) * | 1987-03-02 | 1997-02-04 | Gen-Probe Incorporated | Polycationic supports and nucleic acid purification separation and hybridization |
| AU622104B2 (en) * | 1987-03-11 | 1992-04-02 | Sangtec Molecular Diagnostics Ab | Method of assaying of nucleic acids, a reagent combination and kit therefore |
| CA1317860C (en) * | 1987-04-01 | 1993-05-18 | Daniel Louis Kacian | Techniques for preparing specimens for bacterial assays |
| US6270961B1 (en) * | 1987-04-01 | 2001-08-07 | Hyseq, Inc. | Methods and apparatus for DNA sequencing and DNA identification |
| GB8709803D0 (en) * | 1987-04-24 | 1987-05-28 | Mcfadden J J | Treatment of crohn's disease &c |
| US5225324A (en) * | 1987-04-24 | 1993-07-06 | Bioscience International, Inc. | Diagnostics for mycobacteria in public health, medical, and veterinary practice |
| US5273879A (en) * | 1987-07-23 | 1993-12-28 | Syntex (U.S.A.) Inc. | Amplification method for polynucleotide assays |
| US4994368A (en) * | 1987-07-23 | 1991-02-19 | Syntex (U.S.A.) Inc. | Amplification method for polynucleotide assays |
| AU623090B2 (en) * | 1987-07-31 | 1992-05-07 | Gen-Probe Incorporated | Assay for polynucleotides employing oligonucleotides to eliminate undesirable cross reactions |
| US5089386A (en) * | 1987-09-11 | 1992-02-18 | Gene-Trak Systems | Test for listeria |
| US5656731A (en) * | 1987-10-15 | 1997-08-12 | Chiron Corporation | Nucleic acid-amplified immunoassay probes |
| US5359100A (en) * | 1987-10-15 | 1994-10-25 | Chiron Corporation | Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers |
| AU2714988A (en) * | 1987-10-23 | 1989-06-01 | Siska Diagnostics, Inc. | Lanthanide chelate-tagged nucleic acid probes |
| US6013531A (en) * | 1987-10-26 | 2000-01-11 | Dade International Inc. | Method to use fluorescent magnetic polymer particles as markers in an immunoassay |
| CA1340506C (en) * | 1987-11-24 | 1999-04-20 | Nicholas H. Carbonetti | Production of gonorrheal pi proteins and vaccines |
| US6348332B1 (en) | 1987-11-24 | 2002-02-19 | The University Of North Carolina At Chapel Hill | DNA molecule encoding gonorrhoeal hybrid PIA/PIB protein |
| DE3854943T2 (en) * | 1987-12-01 | 1996-09-05 | Amoco Corp | DETECTION OF SALMONELLA |
| US5354657A (en) * | 1988-01-12 | 1994-10-11 | Boehringer Mannheim Gmbh | Process for the highly specific detection of nucleic acids in solid |
| US20050019760A1 (en) * | 1988-03-05 | 2005-01-27 | Oxford Gene Technology Limited | Analysing polynucleotide sequences |
| GB8810400D0 (en) | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
| US7811751B2 (en) | 1988-05-03 | 2010-10-12 | Oxford Gene Technology Limited | Analysing polynucleotide sequences |
| US5700637A (en) * | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US6054270A (en) * | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
| WO1989010979A1 (en) * | 1988-05-10 | 1989-11-16 | E.I. Du Pont De Nemours And Company | Process for rapid nucleic acid detection |
| US5024933A (en) * | 1988-05-10 | 1991-06-18 | Enzo Biochem, Inc. | Method and kit for sample adherence to test substrate |
| US5294533A (en) * | 1988-07-05 | 1994-03-15 | Baylor College Of Medicine | Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
| US5047523A (en) * | 1988-08-02 | 1991-09-10 | Ortho Diagnostic Systems Inc. | Nucleic acid probe for detection of neisseria gonorrhoea |
| US5185243A (en) * | 1988-08-25 | 1993-02-09 | Syntex (U.S.A.) Inc. | Method for detection of specific nucleic acid sequences |
| WO1990006372A1 (en) * | 1988-12-01 | 1990-06-14 | Microprobe Corporation | Substrates for peroxidase assaying |
| US7172863B1 (en) | 1988-12-09 | 2007-02-06 | Gen-Probe Incorporated | Nucleic acid probes and methods for detecting Neisseria gonorrhoeae |
| US5324829A (en) * | 1988-12-16 | 1994-06-28 | Ortho Diagnostic Systems, Inc. | High specific activity nucleic acid probes having target recognition and signal generating moieties |
| GR1000347B (en) * | 1988-12-21 | 1992-06-25 | Ortho Diagnostic Systems Inc | Method of preparing nucleotide probes using a bridging complement |
| US5237016A (en) * | 1989-01-05 | 1993-08-17 | Siska Diagnostics, Inc. | End-attachment of oligonucleotides to polyacrylamide solid supports for capture and detection of nucleic acids |
| US5514550A (en) * | 1989-02-03 | 1996-05-07 | Johnson & Johnson Clinical Diagnostics, Inc. | Nucleic acid test article and its use to detect a predetermined nucleic acid |
| CA2009708A1 (en) * | 1989-02-13 | 1990-08-13 | Jane D. Madonna | Nucleic acid probe for the detection of salmonella human pathogens |
| US5856092A (en) * | 1989-02-13 | 1999-01-05 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
| US5049489A (en) * | 1989-04-17 | 1991-09-17 | The Standard Oil Company | 16S rRNA oligonucleotide probes for the identification of sulfate-reducing bacteria |
| US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6919211B1 (en) | 1989-06-07 | 2005-07-19 | Affymetrix, Inc. | Polypeptide arrays |
| US6379895B1 (en) | 1989-06-07 | 2002-04-30 | Affymetrix, Inc. | Photolithographic and other means for manufacturing arrays |
| US5925525A (en) * | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
| US6551784B2 (en) | 1989-06-07 | 2003-04-22 | Affymetrix Inc | Method of comparing nucleic acid sequences |
| US6955915B2 (en) * | 1989-06-07 | 2005-10-18 | Affymetrix, Inc. | Apparatus comprising polymers |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| EP0405592A3 (en) * | 1989-06-30 | 1991-07-17 | Sanyo Chemical Industries Ltd. | A method for detection of nucleic acid and reagents for their detection |
| US5106730A (en) * | 1989-07-24 | 1992-04-21 | Microprobe Corporation | Lactam-containing compositions and methods useful for the hybridization of nucleic acids |
| US5232829A (en) * | 1989-09-29 | 1993-08-03 | Hoffmann-La Roche Inc. | Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes |
| CA2028012A1 (en) * | 1989-10-23 | 1991-04-24 | Randall Dimond | Hybridization assay for campylobacter rrna |
| GB8924989D0 (en) * | 1989-11-06 | 1989-12-28 | Scotgen Ltd | Method and device for the detection of antibiotic resistance |
| ATE148746T1 (en) * | 1989-12-14 | 1997-02-15 | Dade Int Inc | MAGNETIC AND FLUORESCENT POLYMER PARTICLES AND THEIR APPLICATION |
| CA2032203C (en) * | 1989-12-29 | 2009-05-19 | Christine L. Brakel | Amplification capture assay |
| CA2075186A1 (en) * | 1990-02-02 | 1991-08-03 | Rudi Rossau | Hybridization probes for the detection of branhamella catarrhalis strains |
| US5721097A (en) * | 1990-02-02 | 1998-02-24 | N. V. Innogenetics S.A. | Hybridization probes for the detection of branhamella catarrhalis strains |
| US6013431A (en) * | 1990-02-16 | 2000-01-11 | Molecular Tool, Inc. | Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators |
| US5200314A (en) * | 1990-03-23 | 1993-04-06 | Chiron Corporation | Polynucleotide capture assay employing in vitro amplification |
| AU7429591A (en) * | 1990-04-18 | 1991-10-24 | Gene-Trak Systems | Nucleic acid probes for the detection of giardia lamblia |
| AU659798B2 (en) * | 1990-05-04 | 1995-06-01 | Chiron Corporation | Protein-nucleic acid probes and immunoassays using same |
| US5670316A (en) * | 1990-05-07 | 1997-09-23 | Daikin Industries, Ltd. | Diagnostic applications of double D-loop formation |
| US5232830A (en) * | 1990-05-11 | 1993-08-03 | Microprobe Corporation | Intrinsic fluorescent quenching methods |
| US5695926A (en) * | 1990-06-11 | 1997-12-09 | Bio Merieux | Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support |
| NZ239084A (en) * | 1990-07-24 | 1994-09-27 | Uab Research Foundation | Bovine respiratory virus (brs) f glycoprotein and vaccine therefrom |
| US6730305B1 (en) | 2000-05-08 | 2004-05-04 | The Uab Research Foundation | Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins |
| IL99025A0 (en) * | 1990-08-15 | 1992-07-15 | Astra Ab | Novel process for the detection of pathogens using dna probes |
| WO1992008808A1 (en) * | 1990-11-14 | 1992-05-29 | Siska Diagnostics, Inc. | Non-isotopic detection of nucleic acids using a polystyrene support-based sandwich hybridization assay and compositions useful therefor |
| AU1248292A (en) * | 1990-12-06 | 1992-07-08 | Affymax Technologies N.V. | Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides |
| USH1398H (en) * | 1990-12-28 | 1995-01-03 | Campbell; James R. | DNA-based fluourescent sensor |
| EP0497464A1 (en) * | 1991-01-31 | 1992-08-05 | Amoco Corporation | Rapid microbial diagnostics by in situ hybridization in aqueous suspension |
| ES2108109T3 (en) * | 1991-02-14 | 1997-12-16 | Dade Microscan Inc | NEW OLIGONUCLEOTIDES CONJUGATED WITH LANTANIDES CHELATES. |
| US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
| WO1992018647A1 (en) * | 1991-04-15 | 1992-10-29 | Sumitomo Electric Industries, Ltd. | Process for separating or extracting nucleic acid from specimen containing the same |
| US5556748A (en) * | 1991-07-30 | 1996-09-17 | Xenopore Corporation | Methods of sandwich hybridization for the quantitative analysis of oligonucleotides |
| US5612199A (en) * | 1991-10-11 | 1997-03-18 | Behringwerke Ag | Method for producing a polynucleotide for use in single primer amplification |
| DK0549107T3 (en) | 1991-10-11 | 1998-08-31 | Dade Behring Marburg Gmbh | Process for Preparing a Polynucleotide for Use in Single Primer Amplification and Phosphorothioate-Containing Oils |
| US5849486A (en) * | 1993-11-01 | 1998-12-15 | Nanogen, Inc. | Methods for hybridization analysis utilizing electrically controlled hybridization |
| US6652808B1 (en) * | 1991-11-07 | 2003-11-25 | Nanotronics, Inc. | Methods for the electronic assembly and fabrication of devices |
| US6017696A (en) * | 1993-11-01 | 2000-01-25 | Nanogen, Inc. | Methods for electronic stringency control for molecular biological analysis and diagnostics |
| US5632957A (en) | 1993-11-01 | 1997-05-27 | Nanogen | Molecular biological diagnostic systems including electrodes |
| US6051380A (en) * | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
| US5605662A (en) | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
| US6048690A (en) * | 1991-11-07 | 2000-04-11 | Nanogen, Inc. | Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis |
| US6569382B1 (en) | 1991-11-07 | 2003-05-27 | Nanogen, Inc. | Methods apparatus for the electronic, homogeneous assembly and fabrication of devices |
| ES2049618B1 (en) * | 1991-11-13 | 1994-11-01 | Consejo Superior Investigacion | DIAGNOSTIC METHOD AND CLASSIFICATION OF TRYPANOSOMA CRUZI SPECIES. |
| WO1993020234A1 (en) * | 1992-03-31 | 1993-10-14 | E.I. Du Pont De Nemours And Company | A rapid, high capacity nucleic acid based assay |
| US6100099A (en) | 1994-09-06 | 2000-08-08 | Abbott Laboratories | Test strip having a diagonal array of capture spots |
| DE4212555A1 (en) * | 1992-04-15 | 1993-10-21 | Boehringer Mannheim Gmbh | Methods for the detection of nucleic acids |
| US5543292A (en) * | 1992-06-16 | 1996-08-06 | Hitachi, Ltd. | Process for the measurement of nucleic acids |
| WO1994003637A1 (en) * | 1992-07-31 | 1994-02-17 | Syntex (Usa) Inc. | Method for introducing defined sequences at the 3' end of polynucleotides |
| US7713528B1 (en) | 1993-02-18 | 2010-05-11 | Enzo Therapeutics, Inc. | Method for in vivo delivery of active compounds using reagent conjugate |
| US6294323B1 (en) | 1993-04-14 | 2001-09-25 | Behringwerke Ag | Self initiating single primer amplification of nucleic acids |
| CA2163249A1 (en) * | 1993-05-28 | 1994-12-08 | Henri Tiedge | Bc200 rna, probes therefor and use thereof |
| DE4344742A1 (en) * | 1993-06-09 | 1994-12-15 | Boehringer Mannheim Gmbh | Method for the immobilization of nucleic acids |
| US5532122A (en) * | 1993-10-12 | 1996-07-02 | Biotraces, Inc. | Quantitation of gamma and x-ray emitting isotopes |
| US5854084A (en) | 1996-07-12 | 1998-12-29 | Biotraces, Inc. | Enhanced chromatography using multiphoton detection |
| US6638482B1 (en) | 1993-11-01 | 2003-10-28 | Nanogen, Inc. | Reconfigurable detection and analysis apparatus and method |
| US7101661B1 (en) | 1993-11-01 | 2006-09-05 | Nanogen, Inc. | Apparatus for active programmable matrix devices |
| US6254827B1 (en) | 1993-11-01 | 2001-07-03 | Nanogen, Inc. | Methods for fabricating multi-component devices for molecular biological analysis and diagnostics |
| US6375899B1 (en) | 1993-11-01 | 2002-04-23 | Nanogen, Inc. | Electrophoretic buss for transport of charged materials in a multi-chamber system |
| US6225059B1 (en) | 1993-11-01 | 2001-05-01 | Nanogen, Inc. | Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics |
| US6331274B1 (en) | 1993-11-01 | 2001-12-18 | Nanogen, Inc. | Advanced active circuits and devices for molecular biological analysis and diagnostics |
| US7314708B1 (en) | 1998-08-04 | 2008-01-01 | Nanogen, Inc. | Method and apparatus for electronic synthesis of molecular structures |
| US20040077074A1 (en) * | 1993-11-01 | 2004-04-22 | Nanogen, Inc. | Multi-chambered analysis device |
| US6315953B1 (en) * | 1993-11-01 | 2001-11-13 | Nanogen, Inc. | Devices for molecular biological analysis and diagnostics including waveguides |
| US6726880B1 (en) | 1993-11-01 | 2004-04-27 | Nanogen, Inc. | Electronic device for performing active biological operations and method of using same |
| US7582421B2 (en) * | 1993-11-01 | 2009-09-01 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
| US6309602B1 (en) | 1993-11-01 | 2001-10-30 | Nanogen, Inc. | Stacked, reconfigurable system for electrophoretic transport of charged materials |
| US7172864B1 (en) | 1993-11-01 | 2007-02-06 | Nanogen | Methods for electronically-controlled enzymatic reactions |
| US6068818A (en) * | 1993-11-01 | 2000-05-30 | Nanogen, Inc. | Multicomponent devices for molecular biological analysis and diagnostics |
| US6287517B1 (en) | 1993-11-01 | 2001-09-11 | Nanogen, Inc. | Laminated assembly for active bioelectronic devices |
| US6319472B1 (en) | 1993-11-01 | 2001-11-20 | Nanogen, Inc. | System including functionally separated regions in electrophoretic system |
| CA2176496C (en) * | 1993-11-29 | 1999-09-28 | Kathleen A. Clark | Method for extracting nucleic acids from a wide range of organisms |
| BR9507343A (en) * | 1994-04-04 | 1997-09-16 | Ciba Corning Diagnostics Corp | Hybridization tests - binding for the detection of specific nucleic acid sequences |
| US5807522A (en) * | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
| US7378236B1 (en) | 1994-06-17 | 2008-05-27 | The Board Of Trustees Of The Leland Stanford Junior University | Method for analyzing gene expression patterns |
| US7323298B1 (en) * | 1994-06-17 | 2008-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Microarray for determining the relative abundances of polynuceotide sequences |
| US6379897B1 (en) * | 2000-11-09 | 2002-04-30 | Nanogen, Inc. | Methods for gene expression monitoring on electronic microarrays |
| US7857957B2 (en) * | 1994-07-07 | 2010-12-28 | Gamida For Life B.V. | Integrated portable biological detection system |
| US6403367B1 (en) * | 1994-07-07 | 2002-06-11 | Nanogen, Inc. | Integrated portable biological detection system |
| US5545527A (en) | 1994-07-08 | 1996-08-13 | Visible Genetics Inc. | Method for testing for mutations in DNA from a patient sample |
| US8236493B2 (en) | 1994-10-21 | 2012-08-07 | Affymetrix, Inc. | Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA |
| CA2163393C (en) * | 1994-11-30 | 2003-04-22 | Colleen Marie Nycz | Amplification and detection of mycobacteria nucleic acids |
| US5783387A (en) * | 1995-02-06 | 1998-07-21 | The Regents Of The University Of California | Method for identifying and quantifying nucleic acid sequence aberrations |
| US5731153A (en) * | 1996-08-26 | 1998-03-24 | The Regents Of The University Of California | Identification of random nucleic acid sequence aberrations using dual capture probes which hybridize to different chromosome regions |
| US5610023A (en) * | 1995-03-31 | 1997-03-11 | Lee Laboratories, Inc. | Method of purification of clostridium difficile toxin A and production of mono-specific antibodies |
| US5783453A (en) * | 1995-06-29 | 1998-07-21 | Chiron Diagnostics Corporation | Non-separation specific binding chemiluminescent assay |
| US6027879A (en) * | 1995-08-09 | 2000-02-22 | The Regents Of The University Of California | Detection and isolation of nucleic acid sequences using a bifunctional hybridization probe |
| US5616465A (en) | 1995-08-09 | 1997-04-01 | The Regents Of The University Of California | Detection and isolation of nucleic acid sequences using competitive hybridization probes |
| US5770365A (en) * | 1995-08-25 | 1998-06-23 | Tm Technologies, Inc. | Nucleic acid capture moieties |
| US20040086917A1 (en) * | 1995-09-27 | 2004-05-06 | Nanogen, Inc. | Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | Nucleic acid analysis techniques |
| AU2320597A (en) | 1996-03-19 | 1997-10-10 | Molecular Tool, Inc. | Method for determining the nucleotide sequence of a polynucleotide |
| US5814490A (en) * | 1996-06-11 | 1998-09-29 | Becton, Dickinson And Company | Amplification and detection of chlamydia trachomatis nucleic acids |
| US5910410A (en) * | 1996-09-06 | 1999-06-08 | Hewlett-Packard Company | Dual tag binding assay |
| US5853993A (en) * | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
| US6706473B1 (en) | 1996-12-06 | 2004-03-16 | Nanogen, Inc. | Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides |
| CA2276462C (en) * | 1996-12-31 | 2007-06-12 | Genometrix Incorporated | Multiplexed molecular analysis system apparatus and method |
| RU2121507C1 (en) * | 1997-02-18 | 1998-11-10 | Мавзютов Айрат Радикович | Method of determination of thermostable enterotoxin gene in examples of enterobacteriaceae family |
| US6534273B2 (en) | 1997-05-02 | 2003-03-18 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
| WO1998050583A1 (en) | 1997-05-02 | 1998-11-12 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
| DE19741715A1 (en) * | 1997-09-22 | 1999-03-25 | Hoechst Ag | New pentopyranosyl nucleoside compounds |
| AU746061B2 (en) * | 1997-12-12 | 2002-04-11 | Qiagen Gaithersburg, Inc. | Assessment of human papilloma virus-related disease |
| US6458533B1 (en) | 1997-12-19 | 2002-10-01 | High Throughput Genomics, Inc. | High throughput assay system for monitoring ESTs |
| US20100105572A1 (en) * | 1997-12-19 | 2010-04-29 | Kris Richard M | High throughput assay system |
| US20030039967A1 (en) * | 1997-12-19 | 2003-02-27 | Kris Richard M. | High throughput assay system using mass spectrometry |
| US20030096232A1 (en) * | 1997-12-19 | 2003-05-22 | Kris Richard M. | High throughput assay system |
| US6232066B1 (en) | 1997-12-19 | 2001-05-15 | Neogen, Inc. | High throughput assay system |
| US6238869B1 (en) | 1997-12-19 | 2001-05-29 | High Throughput Genomics, Inc. | High throughput assay system |
| EP2156891A3 (en) | 1998-05-01 | 2010-06-02 | Gen-Probe Incorporated | System and method for incubating the contents of a reaction receptacle |
| DE19824900B4 (en) | 1998-06-04 | 2006-05-04 | Roche Diagnostics Gmbh | DNA detection via a strand-annealing complex |
| EP1988165A1 (en) | 1999-03-31 | 2008-11-05 | The University of North Carolina at Chapel Hill | Isolated DNA encoding cullin regulator ROC1, isolated proteins encoded by the same, and methods utilizing the same |
| US6235479B1 (en) | 1999-04-13 | 2001-05-22 | Bio Merieux, Inc. | Methods and devices for performing analysis of a nucleic acid sample |
| US7101989B1 (en) | 1999-07-09 | 2006-09-05 | University Of North Carolina At Chapel Hill | DsrA protein and polynucleotides encoding the same |
| FR2803913B1 (en) * | 2000-01-13 | 2002-08-16 | Pasteur Sanofi Diagnostics | METHOD OF IMMOBILIZING AFFIN (A) REAGENT (S) ON A HYDROPHOBIC SOLID PHASE |
| US7582420B2 (en) | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
| US7955794B2 (en) | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
| US8076063B2 (en) * | 2000-02-07 | 2011-12-13 | Illumina, Inc. | Multiplexed methylation detection methods |
| DE60136166D1 (en) * | 2000-02-07 | 2008-11-27 | Illumina Inc | NUCLEIC ACID PROOF METHOD WITH UNIVERSAL PRIMING |
| US20050214825A1 (en) * | 2000-02-07 | 2005-09-29 | John Stuelpnagel | Multiplex sample analysis on universal arrays |
| US20020051981A1 (en) * | 2000-03-08 | 2002-05-02 | Robert Getts | Methods for assay and detection on a microarray |
| AU3460600A (en) * | 2000-03-16 | 2001-09-24 | Bionex, Inc. | Method for detecting mutation of nucleic acid |
| US7439016B1 (en) * | 2000-06-15 | 2008-10-21 | Digene Corporation | Detection of nucleic acids by type-specific hybrid capture method |
| US7601497B2 (en) * | 2000-06-15 | 2009-10-13 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by target-specific hybrid capture method |
| US20040185464A1 (en) * | 2000-09-15 | 2004-09-23 | Kris Richard M. | High throughput assay system |
| US20020169562A1 (en) * | 2001-01-29 | 2002-11-14 | Gregory Stephanopoulos | Defining biological states and related genes, proteins and patterns |
| AU2002327236A1 (en) | 2001-07-12 | 2003-01-29 | Illumina, Inc. | Multiplex nucleic acid reactions |
| US6893822B2 (en) | 2001-07-19 | 2005-05-17 | Nanogen Recognomics Gmbh | Enzymatic modification of a nucleic acid-synthetic binding unit conjugate |
| US20050147984A1 (en) * | 2001-08-31 | 2005-07-07 | Clondiag Chip Technologies Gmbh | Interaction detection on several probe arrays |
| US6696254B2 (en) * | 2001-11-21 | 2004-02-24 | Kimberly-Clark Worldwide, Inc. | Detection and identification of enteric bacteria |
| US7041811B2 (en) * | 2001-12-19 | 2006-05-09 | Dr. Chip Biotechnology, Inc. | Method for detecting Escherichia coli |
| US20030175709A1 (en) * | 2001-12-20 | 2003-09-18 | Murphy George L. | Method and system for depleting rRNA populations |
| US7579147B2 (en) * | 2002-05-07 | 2009-08-25 | Wake Forest University Health Sciences | Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease |
| ES2594333T3 (en) * | 2002-05-17 | 2016-12-19 | Becton, Dickinson And Company | Automated system to isolate, amplify and detect a white nucleic acid sequence |
| US20030219755A1 (en) * | 2002-05-24 | 2003-11-27 | Nanibhushan Dattagupta | Compositions and methods for performing hybridization assays using target enhanced signal amplification (TESA) |
| US7601493B2 (en) * | 2002-07-26 | 2009-10-13 | Nanogen, Inc. | Methods and apparatus for screening and detecting multiple genetic mutations |
| US20040259105A1 (en) * | 2002-10-03 | 2004-12-23 | Jian-Bing Fan | Multiplex nucleic acid analysis using archived or fixed samples |
| WO2004041192A2 (en) * | 2002-10-31 | 2004-05-21 | Pfizer Products, Inc. | Panels of molecular targets differentially expressed during cd8+ t-cell priming |
| AU2003302472B2 (en) * | 2002-11-22 | 2010-10-21 | The Johns Hopkins University | Target for therapy of cognitive impairment |
| ATE479775T1 (en) * | 2002-11-26 | 2010-09-15 | Univ Maryland Biotechnology | HIGHLY SENSITIVE ASSAY FOR PATHOGENE DETECTION USING METAL ENHANCED FLUORESCENCE |
| US20040235019A1 (en) * | 2003-03-06 | 2004-11-25 | Agouron Pharmaceuticals, Inc. | Diagnostics and therapeutics for the gene expression signature of PPAR-gamma receptor ligand |
| CA2525413C (en) | 2003-05-19 | 2010-08-17 | Gen-Probe Incorporated | Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample |
| CA2545917C (en) | 2003-11-14 | 2014-07-29 | Duke University | Methods of detecting charcot-marie tooth disease type 2a |
| GB0411081D0 (en) * | 2004-05-18 | 2004-06-23 | Glaxo Group Ltd | Novel apparatus |
| WO2006007567A2 (en) | 2004-07-01 | 2006-01-19 | Gen-Probe Incorporated | Methods and compositions to detect nucleic acids in a biological sample |
| US7662562B2 (en) * | 2004-08-10 | 2010-02-16 | Becton, Dickinson And Company | Method for rapid identification of microorganisms |
| US7828954B2 (en) * | 2004-09-21 | 2010-11-09 | Gamida For Life B.V. | Electrode based patterning of thin film self-assembled nanoparticles |
| US7314542B2 (en) * | 2004-09-23 | 2008-01-01 | Nanogen, Inc. | Methods and materials for optimization of electronic transportation and hybridization reactions |
| EP1921454B1 (en) | 2005-03-10 | 2015-08-12 | Gen-Probe Incorporated | Systems and methods to perform assays for detecting or quantifying analytes |
| US7932081B2 (en) | 2005-03-10 | 2011-04-26 | Gen-Probe Incorporated | Signal measuring system for conducting real-time amplification assays |
| WO2006110314A2 (en) | 2005-03-25 | 2006-10-19 | Ambion, Inc. | Methods and compositions for depleting abundant rna transcripts |
| ATE551433T1 (en) | 2005-05-06 | 2012-04-15 | Gen Probe Inc | METHOD AND PRODUCTS FOR DETECTING NUCLEIC ACID TARGETS |
| WO2008060369A2 (en) | 2006-09-29 | 2008-05-22 | Translational Therapeutics, Inc. | Eif4e regulon-based diagnostics |
| WO2007123579A2 (en) | 2005-12-28 | 2007-11-01 | Translational Therapeutics | Translational dysfunction based therapeutics |
| US20070186298A1 (en) * | 2006-01-04 | 2007-08-09 | Blowe Charlotte D | Follistatin gene as a genetic marker for reproductive and performance traits in pigs |
| US20080118914A1 (en) * | 2006-01-04 | 2008-05-22 | Charlotte Dawn Blowe | Follistatin gene as a genetic marker for first parity litter size in pigs |
| EP2027293B1 (en) | 2006-05-24 | 2014-11-19 | Gen-Probe Incorporated | Method of lysing mycobacterium and amplifying its nucleic acid |
| EP2017356B1 (en) | 2006-06-06 | 2011-12-07 | Gen-Probe Incorporated | Tagged oliggonucleotides and their use in nucleic acid amplification methods |
| US9938641B2 (en) * | 2006-12-18 | 2018-04-10 | Fluidigm Corporation | Selection of aptamers based on geometry |
| EP1978111B1 (en) | 2007-04-02 | 2013-03-27 | Gen-Probe Incorporated | Compositions, kits and related methods for the detection and/or monitoring of Pseudomonas aeruginosa |
| CA2709356C (en) | 2007-12-21 | 2019-08-06 | Biomerieux Sa | Detection of methicillin-resistant staphylococcus aureus |
| WO2009126336A1 (en) * | 2008-04-11 | 2009-10-15 | Becton, Dickinson And Company | Methods of controlling the sensitivity and dynamic range of a homogeneous assay |
| EP2479287B1 (en) | 2008-05-13 | 2014-07-23 | Gen-Probe Incorporated | Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences |
| CA2723917A1 (en) | 2008-05-30 | 2009-12-30 | Gen-Probe Incorporated | Compositions, kits and related methods for the detection and/or monitoring of salmonella |
| US8815508B2 (en) | 2008-08-12 | 2014-08-26 | Zinfandel Pharmaceuticals, Inc. | Method of identifying disease risk factors |
| TWI419974B (en) * | 2008-10-27 | 2013-12-21 | Qiagen Gaithersburg Inc | Fast results hybrid capture assay on an automated platform |
| US8399222B2 (en) * | 2008-11-25 | 2013-03-19 | Gen-Probe Incorporated | Compositions and methods for detecting small RNAs, and uses thereof |
| EP2389449B1 (en) | 2008-12-30 | 2015-02-18 | Gen-Probe Incorporated | Compositions, kits and related methods for the detection and/or monitoring of listeria |
| US20100216147A1 (en) * | 2009-01-28 | 2010-08-26 | Qiagen Gaithersburg, Inc. | Sequence-specific large volume sample preparation method and assay |
| AU2010242867B2 (en) * | 2009-05-01 | 2016-05-12 | Qiagen Gaithersburg, Inc. | A non-target amplification method for detection of RNA splice-forms in a sample |
| CN105618264B (en) | 2009-05-15 | 2021-04-06 | 简·探针公司 | Method and apparatus for implementing automatic movement of a magnet in an instrument performing a magnetic separation procedure |
| EP2473624B1 (en) | 2009-08-31 | 2019-05-01 | Gen-Probe Incorporated | Dengue virus assay |
| US9410146B2 (en) | 2009-09-14 | 2016-08-09 | Qiagen Gaithersburg Inc. | Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media |
| CA2787958A1 (en) | 2009-12-21 | 2011-07-14 | Becton, Dickinson And Company | Methods for identifying drug resistant mycobacterium |
| US9404160B2 (en) | 2009-12-22 | 2016-08-02 | Becton, Dickinson And Company | Methods for the detection of microorganisms |
| US8790879B2 (en) | 2010-01-22 | 2014-07-29 | Gen-Probe Incorporated | Probes for detecting the presence of Trichomonas vaginalis in a sample |
| US9689047B2 (en) | 2010-01-29 | 2017-06-27 | Qiagen Gaithersburg Inc. | Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
| BR112012018545A2 (en) | 2010-01-29 | 2016-05-03 | Qiagen Gaithersburg Inc | method of determining and confirming the presence of an hpv in a sample |
| WO2011143291A1 (en) | 2010-05-11 | 2011-11-17 | Dow Agrosciences Llc | Spnk strains |
| CA2799200A1 (en) | 2010-05-19 | 2011-11-24 | Qiagen Gaithersburg, Inc. | Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
| CA2799205A1 (en) | 2010-05-25 | 2011-12-01 | Qiagen Gaithersburg, Inc. | Fast results hybrid capture assay and associated strategically-truncated probes |
| EP2752668A3 (en) | 2010-07-23 | 2014-10-15 | Beckman Coulter, Inc. | System Or Method Of Including Analytical Units |
| EP2678442B1 (en) | 2011-02-24 | 2019-01-16 | QIAGEN Gaithersburg, Inc. | Materials and methods for detection of hpv nucleic acid |
| EP2520653B1 (en) | 2011-05-03 | 2017-03-29 | Dow AgroSciences LLC | Integration of genes into the chromosome of saccharopolyspora spinosa |
| EP3225698B1 (en) | 2011-09-06 | 2019-07-31 | Gen-Probe Incorporated | Closed nucleic acid structures |
| DE102011114984B3 (en) * | 2011-09-28 | 2012-11-22 | Universität Rostock | Sequence-specific analysis of nucleic acids |
| EP2776846B1 (en) | 2011-11-07 | 2019-08-21 | Beckman Coulter, Inc. | Aliquotter system and workflow |
| CN103975245A (en) | 2011-11-07 | 2014-08-06 | 贝克曼考尔特公司 | Magnetic damping for specimen transport system |
| KR20140092378A (en) | 2011-11-07 | 2014-07-23 | 베크만 컬터, 인코포레이티드 | System and method for processing samples |
| WO2013070754A1 (en) | 2011-11-07 | 2013-05-16 | Beckman Coulter, Inc. | Robotic arm |
| EP2776843B1 (en) | 2011-11-07 | 2019-03-27 | Beckman Coulter, Inc. | Centrifuge system and workflow |
| BR112014011043A2 (en) | 2011-11-07 | 2017-06-13 | Beckman Coulter Inc | specimen container detection |
| US9394573B2 (en) | 2011-12-23 | 2016-07-19 | Biomerieux S.A. | Detection of mecA variant strains of methicillin-resistant Staphylococcus aureus |
| US9631195B2 (en) | 2011-12-28 | 2017-04-25 | Dow Agrosciences Llc | Identification and characterization of the spinactin biosysnthesis gene cluster from spinosyn producing saccharopolyspora spinosa |
| EP2843047B1 (en) | 2012-02-27 | 2019-10-30 | Toray Industries, Inc. | Nucleic acid detection method |
| WO2013181553A2 (en) | 2012-06-01 | 2013-12-05 | Akron Biotech | Detection of mycoplasma in cell cultures and cell culture derived biologicals |
| WO2014006025A2 (en) | 2012-07-02 | 2014-01-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Marker of pathogenicity in salmonella |
| CA2883499C (en) | 2012-08-31 | 2020-07-14 | Toray Industries, Inc. | Method for detecting target nucleic acid |
| US10427162B2 (en) | 2016-12-21 | 2019-10-01 | Quandx Inc. | Systems and methods for molecular diagnostics |
| CA3108105A1 (en) | 2018-08-08 | 2020-02-13 | Gen-Probe Incorporated | Compositions, methods and kits for detecting mycoplasma genitalium |
| AU2020210753A1 (en) | 2019-01-25 | 2021-09-02 | Gen-Probe Incorporated | Detection of drug-resistant mycoplasma genitalium |
| US20220298548A1 (en) | 2019-08-23 | 2022-09-22 | Gen-Probe Incorporated | Compositions, methods and kits for detecting treponema pallidum |
| CA3188657A1 (en) | 2020-07-17 | 2022-01-20 | Gen-Probe Incorporated | Detection of macrolide-resistant mycoplasma genitalium |
| WO2024099985A1 (en) | 2022-11-10 | 2024-05-16 | Bayer Aktiengesellschaft | Targeted crop protection product application based on genetic profiles |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896217A (en) * | 1973-03-19 | 1975-07-22 | Summa Corp | Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent |
| US3930956A (en) * | 1973-10-29 | 1976-01-06 | The Regents Of The University Of Michigan | Method for the genetic detection of microorganisms |
| SU649751A1 (en) * | 1977-06-14 | 1979-02-28 | Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.М.В.Ломоносова | Method of identification of microorganisms |
| US4139346A (en) * | 1977-11-28 | 1979-02-13 | Enzo Bio Chem Incorporated | Nucleic acid and protein binding paper |
| FR2422956A1 (en) * | 1978-04-13 | 1979-11-09 | Pasteur Institut | METHOD OF DETECTION AND CHARACTERIZATION OF A NUCLEIC ACID OR OF A SEQUENCE OF THE SAME, AND ENZYMATIC REAGENT FOR THE IMPLEMENTATION OF THIS PROCESS |
| FR2444713A1 (en) * | 1978-12-18 | 1980-07-18 | Pasteur Institut | PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME |
| US4302204A (en) * | 1979-07-02 | 1981-11-24 | The Board Of Trustees Of Leland Stanford Junior University | Transfer and detection of nucleic acids |
| US4359535A (en) * | 1979-10-01 | 1982-11-16 | George Pieczenik | Autonomously replicating DNA containing inserted DNA sequences |
| US4358535A (en) * | 1980-12-08 | 1982-11-09 | Board Of Regents Of The University Of Washington | Specific DNA probes in diagnostic microbiology |
| US4446237A (en) * | 1981-03-27 | 1984-05-01 | Life Technologies, Inc. | Method for detection of a suspect viral deoxyribonucleic acid in an acellular biological fluid |
| EP0062286A1 (en) * | 1981-03-31 | 1982-10-13 | Albert Einstein College Of Medicine Of Yeshiva University | Diagnostic test for hepatitis B virus |
| CA1219824A (en) * | 1981-04-17 | 1987-03-31 | David C. Ward | Modified nucleotides and methods of preparing and using same |
| JPS5840099A (en) * | 1981-07-17 | 1983-03-08 | アモコ・コ−ポレ−ション | Hydrid diagnosis of light projecting polynucleotide |
| FI63596C (en) * | 1981-10-16 | 1983-07-11 | Orion Yhtymae Oy | MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER |
-
1981
- 1981-10-16 FI FI813251A patent/FI63596C/en not_active IP Right Cessation
-
1982
- 1982-09-29 JP JP57-502956A patent/JPH0632637B2/en not_active Expired - Lifetime
- 1982-09-29 WO PCT/FI1982/000038 patent/WO1983001459A1/en not_active Ceased
- 1982-09-29 HU HU823529A patent/HU196242B/en unknown
- 1982-09-29 JP JP57502956A patent/JPS58501703A/en active Granted
- 1982-09-29 AU AU89575/82A patent/AU548854B2/en not_active Expired
- 1982-09-29 EP EP82902982A patent/EP0098267A1/en not_active Withdrawn
- 1982-10-14 US US06/434,182 patent/US4486539A/en not_active Expired - Lifetime
- 1982-10-15 AT AT82305489T patent/ATE31735T1/en not_active IP Right Cessation
- 1982-10-15 CA CA000413539A patent/CA1192120A/en not_active Expired
- 1982-10-15 DE DE8282305489T patent/DE3277917D1/en not_active Expired
- 1982-10-15 DE DE198282305489T patent/DE79139T1/en active Pending
- 1982-10-15 EP EP82305489A patent/EP0079139B1/en not_active Expired
-
1983
- 1983-06-15 DK DK198302751A patent/DK173744B1/en not_active IP Right Cessation
- 1983-11-15 SU SU833663405A patent/SU1386031A3/en active
- 1983-11-15 RO RO112563A patent/RO86356B/en unknown
- 1983-12-29 US US06/566,532 patent/US4563419A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0079139B1 (en) | 1988-01-07 |
| JPH0632637B2 (en) | 1994-05-02 |
| DK275183D0 (en) | 1983-06-15 |
| SU1386031A3 (en) | 1988-03-30 |
| CA1192120A (en) | 1985-08-20 |
| ATE31735T1 (en) | 1988-01-15 |
| DK275183A (en) | 1983-06-15 |
| RO86356A (en) | 1985-03-15 |
| DE3277917D1 (en) | 1988-02-11 |
| RO86356B (en) | 1985-04-01 |
| US4563419A (en) | 1986-01-07 |
| US4486539A (en) | 1984-12-04 |
| FI63596B (en) | 1983-03-31 |
| DK173744B1 (en) | 2001-09-03 |
| EP0079139A1 (en) | 1983-05-18 |
| AU8957582A (en) | 1983-05-05 |
| DE79139T1 (en) | 1983-11-24 |
| WO1983001459A1 (en) | 1983-04-28 |
| JPS58501703A (en) | 1983-10-13 |
| AU548854B2 (en) | 1986-01-02 |
| HU196242B (en) | 1988-10-28 |
| EP0098267A1 (en) | 1984-01-18 |
| JPH0632637B1 (en) | 1994-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI63596C (en) | MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER | |
| EP0133671B1 (en) | Detection of bacteria by nucleic acid hybridization, labeled probes and test kit therefore | |
| US4358535A (en) | Specific DNA probes in diagnostic microbiology | |
| JP2798499B2 (en) | Infectious disease diagnostic probe | |
| US5614388A (en) | PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays | |
| JP2607496B2 (en) | Campylobacter detection probe | |
| EP0133288A2 (en) | Bacterial detection by nucleic acid hybridization, labeled probes and test kit therefore | |
| US5942394A (en) | Detection of protozoan parasites | |
| CN110923362B (en) | Colloidal gold chromatography kit for simultaneously detecting herpes simplex virus type I/II and application thereof | |
| EP0484385A4 (en) | Quantification of bacteria using a nucleic acid hybridization assay | |
| CN114790490A (en) | Molecular marker capable of distinguishing Brucella melitensis and detection method | |
| JP2000511058A (en) | Compositions and methods for detecting Mycobacterium Kansasii | |
| JPH03206899A (en) | Nucleic acid probe and method for use in detection of cryptocox neoholmance | |
| JPH10508499A (en) | Nucleotide sequences that specifically hybridize to Campylobacter genomic nucleic acid sequences | |
| JPH07184697A (en) | Oligonucleotide to detect enterobacteriaceae bacteria | |
| US5348857A (en) | Probes and method for identifying species and biovars of brucella | |
| CN116334255B (en) | A novel nucleic acid detection kit for Salmonella and its non-diagnostic detection method | |
| JP2004290171A (en) | Molecular biological identification technique of microorganism | |
| NO163699B (en) | PROCEDURE AND REAGENT COMBINATION FOR DIAGNOSIS OF MICROORGANISMS. | |
| CN110923347B (en) | Ureaplasma urealyticum nucleic acid detection colloidal gold chromatography kit and application thereof | |
| Begaud et al. | Detection of enterotoxigenic Escherichia coli in faecal specimens by acetylaminofluorene-labelled DNA probes | |
| CN116064943A (en) | Probe, primer set and kit for detecting cat parvovirus and bordetella bronchiseptica and application | |
| WO2025063721A1 (en) | Composition for nucleic acid purification or extraction and use thereof | |
| CN106755423B (en) | Specific sequence-based escherichia coli and shigella detection primer, kit and detection method | |
| CN113652494A (en) | Probe, primer group and kit for detecting helicobacter pylori |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |
Owner name: SANGTEC MOLECULAR DIAGNOSTICS AB |